<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>10500774</id><passage><infon key="name_3">surname:Meuwissen;given-names:Marije E.C.</infon><infon key="name_2">surname:Bael;given-names:An</infon><infon key="name_1">surname:Neven;given-names:Julie</infon><infon key="name_0">surname:Kingma;given-names:Sandra D.K.</infon><infon key="year">2023</infon><infon key="article-id_publisher-id">2889</infon><infon key="article-id_doi">10.1186/s13023-023-02889-x</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="elocation-id">291</infon><infon key="volume">18</infon><infon key="license">Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</infon><infon key="section_type">TITLE</infon><infon key="kwd">Imerslund-Grasbeck syndrome Vitamin B12 deficiency Cobalamin deficiency Vitamin B12 malabsorption</infon><infon key="name_4">surname:van den Akker;given-names:Machiel</infon><infon key="article-id_pmc">10500774</infon><infon key="article-id_pmid">37710296</infon><offset>0</offset><text>Imerslund-Grasbeck syndrome: a comprehensive review of reported cases</text><annotation id="14064"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="0" length="27" /><text>Imerslund-Grasbeck syndrome</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>71</offset><text>Imerslund-Grasbeck syndrome (IGS) is a rare autosomal recessive disorder characterized by vitamin B12 malabsorption. Most patients present with non-specific symptoms attributed to vitamin B12 deficiency, and proteinuria. Patients may if untreated, develop severe neurocognitive manifestations. If recognized and treated with sufficient doses of vitamin B12, patients recover completely. We provide, for the first time, an overview of all previously reported cases of IGS. In addition, we provide a complete review of IGS and describe two new patients.</text><annotation id="14065"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="538" length="3" /><text>IGS</text></annotation><annotation id="14066"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="71" length="27" /><text>Imerslund-Grasbeck syndrome</text></annotation><annotation id="14067"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="429" length="8" /><text>patients</text></annotation><annotation id="14068"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="100" length="3" /><text>IGS</text></annotation><annotation id="14069"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="613" length="8" /><text>patients</text></annotation><annotation id="14070"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="161" length="25" /><text>vitamin B12 malabsorption</text></annotation><annotation id="14071"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="115" length="28" /><text>autosomal recessive disorder</text></annotation><annotation id="14072"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="193" length="8" /><text>patients</text></annotation><annotation id="14073"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="416" length="11" /><text>vitamin B12</text></annotation><annotation id="14074"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="292" length="8" /><text>Patients</text></annotation><annotation id="14075"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="251" length="22" /><text>vitamin B12 deficiency</text></annotation><annotation id="14076"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="279" length="11" /><text>proteinuria</text></annotation><annotation id="14077"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="588" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>624</offset><text>Supplementary Information</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>650</offset><text>The online version contains supplementary material available at 10.1186/s13023-023-02889-x.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>742</offset><text>Background</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>753</offset><text>Imerslund-Grasbeck syndrome (IGS, OMIM 261,100/618,882) is an autosomal recessive disorder characterized by a vitamin B12 (vitB12) deficiency, caused by a selective malabsorption of vitB12, with normal secretion of intrinsic factor (IF) and hydrochloric acid into the stomach. Before the diagnosis of vitB12 deficiency, patients have non-specific symptoms such as failure to thrive, paleness, fatigue, recurring viral infections and mild neurological symptoms. Laboratory examination often reveals macrocytic anemia with or without proteinuria. IGS was first described in 1960 by Imerslund and Grasbeck et al.. The reports included ten and two patients, respectively, although similar cases had been published since the early 19th century. IGS is caused by mutations in the gene CUBN [Genbank NG_008967] encoding cubilin or AMN [Genbank NG_008276] encoding amnionless. Homozygous or compound heterozygous mutations in either CUBN or AMN lead to IGS. Cubilin and amnionless are the two subunits of the vitB12-IF receptor of the ileal mucosa, known as cubam. It is considered essential for intestinal absorption of vitB12, as well as for renal protein reabsorption. Most IGS patients are treated with intra-muscular vitB12, which most frequently corrects the clinical phenotype.</text><annotation id="14078"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="1532" length="4" /><text>CUBN</text></annotation><annotation id="14079"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="1566" length="7" /><text>cubilin</text></annotation><annotation id="14080"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="1577" length="3" /><text>AMN</text></annotation><annotation id="14081"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="1678" length="4" /><text>CUBN</text></annotation><annotation id="14082"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="1686" length="3" /><text>AMN</text></annotation><annotation id="14083"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="1703" length="7" /><text>Cubilin</text></annotation><annotation id="14084"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="1715" length="10" /><text>amnionless</text></annotation><annotation id="14085"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="1610" length="10" /><text>amnionless</text></annotation><annotation id="14087"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="782" length="3" /><text>IGS</text></annotation><annotation id="14088"><infon key="identifier">MESH:D000748</infon><infon key="type">Disease</infon><location offset="1251" length="17" /><text>macrocytic anemia</text></annotation><annotation id="14089"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="1922" length="3" /><text>IGS</text></annotation><annotation id="14090"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="918" length="23" /><text>malabsorption of vitB12</text></annotation><annotation id="14091"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="876" length="6" /><text>vitB12</text></annotation><annotation id="14092"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="1054" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14093"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1926" length="8" /><text>patients</text></annotation><annotation id="14094"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="1698" length="3" /><text>IGS</text></annotation><annotation id="14095"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1397" length="8" /><text>patients</text></annotation><annotation id="14096"><infon key="identifier">MESH:D005221</infon><infon key="type">Disease</infon><location offset="1146" length="7" /><text>fatigue</text></annotation><annotation id="14097"><infon key="identifier">MESH:D005183</infon><infon key="type">Disease</infon><location offset="1117" length="17" /><text>failure to thrive</text></annotation><annotation id="14098"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="1866" length="6" /><text>vitB12</text></annotation><annotation id="14099"><infon key="identifier">MESH:D014777</infon><infon key="type">Disease</infon><location offset="1165" length="16" /><text>viral infections</text></annotation><annotation id="14100"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1073" length="8" /><text>patients</text></annotation><annotation id="14101"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="1285" length="11" /><text>proteinuria</text></annotation><annotation id="14102"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="1191" length="21" /><text>neurological symptoms</text></annotation><annotation id="14103"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="1493" length="3" /><text>IGS</text></annotation><annotation id="14104"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="815" length="28" /><text>autosomal recessive disorder</text></annotation><annotation id="14105"><infon key="identifier">MESH:D006851</infon><infon key="type">Chemical</infon><location offset="994" length="17" /><text>hydrochloric acid</text></annotation><annotation id="14107"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="1298" length="3" /><text>IGS</text></annotation><annotation id="14108"><infon key="identifier">MESH:D006938</infon><infon key="type">Disease</infon><location offset="787" length="20" /><text>OMIM 261,100/618,882</text></annotation><annotation id="14109"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="1967" length="6" /><text>vitB12</text></annotation><annotation id="14110"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="753" length="27" /><text>Imerslund-Grasbeck syndrome</text></annotation><annotation id="14111"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="863" length="11" /><text>vitamin B12</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2032</offset><text>IGS is a rare disorder with an estimated prevalence to be less than 6 per 1,000,000 1. We report on two siblings with IGS, which prompted us to provide an overview of all previously reported cases and a review of IGS.</text><annotation id="14112"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="2150" length="3" /><text>IGS</text></annotation><annotation id="14113"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="2032" length="3" /><text>IGS</text></annotation><annotation id="14114"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="2245" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2250</offset><text>New cases</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2260</offset><text>The patient was a 4-year-old girl of Turkish parents. Medical history was uneventful. Parents were consanguinous, all grandparents were interrelated. The brother of our patient had congenital adrenal deficiency due to a homozygous pathogenic deletion of exon 1-3 of CYP21A2 [Genbank NM_007941] mutation. Futhermore, a sister who was born with hydrops fetalis died three days after birth.</text><annotation id="14115"><infon key="identifier">1589</infon><infon key="type">Gene</infon><location offset="2526" length="7" /><text>CYP21A2</text></annotation><annotation id="14116"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="2429" length="7" /><text>patient</text></annotation><annotation id="14117"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="2289" length="4" /><text>girl</text></annotation><annotation id="14118"><infon key="identifier">MESH:D015160</infon><infon key="type">Disease</infon><location offset="2603" length="15" /><text>hydrops fetalis</text></annotation><annotation id="14119"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="2264" length="7" /><text>patient</text></annotation><annotation id="14120"><infon key="identifier">MESH:D000312</infon><infon key="type">Disease</infon><location offset="2441" length="29" /><text>congenital adrenal deficiency</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2650</offset><text>Our patient presented at our outpatient clinic with three days of fever and coughing. Clinical examination and laboratory analysis suggested a viral infection. Unexpectedly, a slight decrease in hemoglobin was observed, in addition to high mean corpuscular hemoglobin, high mean corpuscular volume, thrombocytopenia, and leukopenia (Table 1). Furthermore, a high lactate dehydrogenase (LDH) and low vitB12 were observed. The peripheral blood smear showed several abnormalities and abnormal cells, with tear drop cells as the most apparent. Teardrop cells are described in a wide range of diseases that are associated with bone marrow fibrosis, such as myelodysplastic syndromes, leukemia, metabolic disorders, hemolytic anemia, iron deficits, thalassemia, but have also been described in macrocytic anemia. There was no evidence of hemolytic anemia, ferritin was in the normal range and hemoglobin electrophoresis showed no evidence of a hemoglobinopathy such as thalassemia.</text><annotation id="14121"><infon key="identifier">MESH:D005334</infon><infon key="type">Disease</infon><location offset="2716" length="5" /><text>fever</text></annotation><annotation id="14122"><infon key="identifier">MESH:D013789</infon><infon key="type">Disease</infon><location offset="3613" length="11" /><text>thalassemia</text></annotation><annotation id="14123"><infon key="identifier">MESH:D000743</infon><infon key="type">Disease</infon><location offset="3482" length="16" /><text>hemolytic anemia</text></annotation><annotation id="14124"><infon key="identifier">MESH:D000748</infon><infon key="type">Disease</infon><location offset="3438" length="17" /><text>macrocytic anemia</text></annotation><annotation id="14125"><infon key="identifier">MESH:D000743</infon><infon key="type">Disease</infon><location offset="3360" length="16" /><text>hemolytic anemia</text></annotation><annotation id="14126"><infon key="identifier">MESH:D055728</infon><infon key="type">Disease</infon><location offset="3272" length="20" /><text>bone marrow fibrosis</text></annotation><annotation id="14127"><infon key="identifier">MESH:D007970</infon><infon key="type">Disease</infon><location offset="2971" length="10" /><text>leukopenia</text></annotation><annotation id="14128"><infon key="identifier">MESH:D013921</infon><infon key="type">Disease</infon><location offset="2949" length="16" /><text>thrombocytopenia</text></annotation><annotation id="14129"><infon key="identifier">MESH:D013789</infon><infon key="type">Disease</infon><location offset="3393" length="11" /><text>thalassemia</text></annotation><annotation id="14130"><infon key="identifier">MESH:D014777</infon><infon key="type">Disease</infon><location offset="2793" length="15" /><text>viral infection</text></annotation><annotation id="14131"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="2654" length="7" /><text>patient</text></annotation><annotation id="14132"><infon key="identifier">MESH:D007938</infon><infon key="type">Disease</infon><location offset="3329" length="8" /><text>leukemia</text></annotation><annotation id="14133"><infon key="identifier">MESH:D003371</infon><infon key="type">Disease</infon><location offset="2726" length="8" /><text>coughing</text></annotation><annotation id="14134"><infon key="identifier">MESH:D008659</infon><infon key="type">Disease</infon><location offset="3339" length="19" /><text>metabolic disorders</text></annotation><annotation id="14135"><infon key="identifier">MESH:D000090463</infon><infon key="type">Disease</infon><location offset="3378" length="13" /><text>iron deficits</text></annotation><annotation id="14136"><infon key="identifier">MESH:D009190</infon><infon key="type">Disease</infon><location offset="3302" length="25" /><text>myelodysplastic syndromes</text></annotation><annotation id="14137"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="2679" length="10" /><text>outpatient</text></annotation><annotation id="14138"><infon key="identifier">MESH:D006453</infon><infon key="type">Disease</infon><location offset="3588" length="16" /><text>hemoglobinopathy</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="type">table_caption</infon><offset>3627</offset><text>Laboratory examination of patient 1</text><annotation id="14139"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="3653" length="7" /><text>patient</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">Tab1.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align="left"/&gt;&lt;th align="left"&gt;Patient&lt;/th&gt;&lt;th align="left"&gt;Unit&lt;/th&gt;&lt;th align="left"&gt;Normal range&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Hemoglobin&lt;/td&gt;&lt;td align="left"&gt;10.7&lt;/td&gt;&lt;td align="left"&gt; g/dL&lt;/td&gt;&lt;td align="left"&gt;11.0-13.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Hematocrit&lt;/td&gt;&lt;td align="left"&gt;0.28&lt;/td&gt;&lt;td align="left"&gt; L/L&lt;/td&gt;&lt;td align="left"&gt;0.32-0.40&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Erythrocyte count&lt;/td&gt;&lt;td align="left"&gt;2.75&lt;/td&gt;&lt;td align="left"&gt; x 10e12/L&lt;/td&gt;&lt;td align="left"&gt;4-5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Mean corpuscular hemoglobin&lt;/td&gt;&lt;td align="left"&gt;39&lt;/td&gt;&lt;td align="left"&gt;pg&lt;/td&gt;&lt;td align="left"&gt;26-30&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Mean corpuscular volume&lt;/td&gt;&lt;td align="left"&gt;103&lt;/td&gt;&lt;td align="left"&gt;fL&lt;/td&gt;&lt;td align="left"&gt;76-87&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Red blood cell distribution width&lt;/td&gt;&lt;td align="left"&gt;30.3&lt;/td&gt;&lt;td align="left"&gt;%&lt;/td&gt;&lt;td align="left"&gt;12.3-14.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Reticulocyte count&lt;/td&gt;&lt;td align="left"&gt;66&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;43-83&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Thrombocyte count&lt;/td&gt;&lt;td align="left"&gt;91&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;193-489&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Leukocyte count&lt;/td&gt;&lt;td align="left"&gt;3.6&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;5-12&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;italic&gt;Peripheral smear&lt;/italic&gt; &lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Neutrophil count&lt;/td&gt;&lt;td align="left"&gt;0.63&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;2.1-8.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Eosinophil count&lt;/td&gt;&lt;td align="left"&gt;0.05&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;0.0-0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Basophil count&lt;/td&gt;&lt;td align="left"&gt;0&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;0.0-0.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Lymphocyte count&lt;/td&gt;&lt;td align="left"&gt;2.89&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;1.2-4.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Monocyte count&lt;/td&gt;&lt;td align="left"&gt;0.02&lt;/td&gt;&lt;td align="left"&gt; x 10e9/L&lt;/td&gt;&lt;td align="left"&gt;0.5-1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Erythroblast count&lt;/td&gt;&lt;td align="left"&gt;5&lt;/td&gt;&lt;td align="left"&gt;/100WBC&lt;/td&gt;&lt;td align="left"&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Blast count&lt;/td&gt;&lt;td align="left"&gt;0&lt;/td&gt;&lt;td align="left"&gt;%&lt;/td&gt;&lt;td align="left"&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;italic&gt;Morphology red blood cells&lt;/italic&gt; &lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Poikilocytosis&lt;/td&gt;&lt;td align="left"&gt;++&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Polychromasia&lt;/td&gt;&lt;td align="left"&gt;++&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Anisocytosis&lt;/td&gt;&lt;td align="left"&gt;+++&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Microcytosis&lt;/td&gt;&lt;td align="left"&gt;+&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Macrocytosis&lt;/td&gt;&lt;td align="left"&gt;+&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Teardrop cells&lt;/td&gt;&lt;td align="left"&gt;+++&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Acanthocytes&lt;/td&gt;&lt;td align="left"&gt;+&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Stomatocytes&lt;/td&gt;&lt;td align="left"&gt;+&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Basophilic inclusions&lt;/td&gt;&lt;td align="left"&gt;+&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Pappenheimer bodies&lt;/td&gt;&lt;td align="left"&gt;+&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Lactate dehydrogenase&lt;/td&gt;&lt;td align="left"&gt;5394&lt;/td&gt;&lt;td align="left"&gt;U/L&lt;/td&gt;&lt;td align="left"&gt;425-975&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Uric acid&lt;/td&gt;&lt;td align="left"&gt;2.9&lt;/td&gt;&lt;td align="left"&gt; mg/dL&lt;/td&gt;&lt;td align="left"&gt;2.2-4.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Creatinine&lt;/td&gt;&lt;td align="left"&gt;&amp;lt; 0.15&lt;/td&gt;&lt;td align="left"&gt; mg/dL&lt;/td&gt;&lt;td align="left"&gt;0.1-0.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Folic acid&lt;/td&gt;&lt;td align="left"&gt;17&lt;/td&gt;&lt;td align="left"&gt;ng/mL&lt;/td&gt;&lt;td align="left"&gt;4-27&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Vitamin B12&lt;/td&gt;&lt;td align="left"&gt;&amp;lt; 100&lt;/td&gt;&lt;td align="left"&gt;ng/L&lt;/td&gt;&lt;td align="left"&gt;313-1410&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Ceruloplasmin&lt;/td&gt;&lt;td align="left"&gt;0.25-0.45&lt;/td&gt;&lt;td align="left"&gt; g/L&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Ferritin&lt;/td&gt;&lt;td align="left"&gt;60&lt;/td&gt;&lt;td align="left"&gt;microg/L&lt;/td&gt;&lt;td align="left"&gt;6-137&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Homocystein&lt;/td&gt;&lt;td align="left"&gt;44&lt;/td&gt;&lt;td align="left"&gt;micromol/L&lt;/td&gt;&lt;td align="left"&gt;&amp;lt; 15&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Bilirubin&lt;/td&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;td align="left"/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">Tab1</infon><infon key="type">table</infon><offset>3663</offset><text>	Patient	Unit	Normal range	 	Hemoglobin	10.7	 g/dL	11.0-13.6	 	Hematocrit	0.28	 L/L	0.32-0.40	 	Erythrocyte count	2.75	 x 10e12/L	4-5	 	Mean corpuscular hemoglobin	39	pg	26-30	 	Mean corpuscular volume	103	fL	76-87	 	Red blood cell distribution width	30.3	%	12.3-14.3	 	Reticulocyte count	66	 x 10e9/L	43-83	 	Thrombocyte count	91	 x 10e9/L	193-489	 	Leukocyte count	3.6	 x 10e9/L	5-12	 	Peripheral smear				 	Neutrophil count	0.63	 x 10e9/L	2.1-8.9	 	Eosinophil count	0.05	 x 10e9/L	0.0-0.3	 	Basophil count	0	 x 10e9/L	0.0-0.5	 	Lymphocyte count	2.89	 x 10e9/L	1.2-4.5	 	Monocyte count	0.02	 x 10e9/L	0.5-1.1	 	Erythroblast count	5	/100WBC	0	 	Blast count	0	%	0	 	Morphology red blood cells				 	Poikilocytosis	++			 	Polychromasia	++			 	Anisocytosis	+++			 	Microcytosis	+			 	Macrocytosis	+			 	Teardrop cells	+++			 	Acanthocytes	+			 	Stomatocytes	+			 	Basophilic inclusions	+			 	Pappenheimer bodies	+			 	Lactate dehydrogenase	5394	U/L	425-975	 	Uric acid	2.9	 mg/dL	2.2-4.7	 	Creatinine	&lt; 0.15	 mg/dL	0.1-0.7	 	Folic acid	17	ng/mL	4-27	 	Vitamin B12	&lt; 100	ng/L	313-1410	 	Ceruloplasmin	0.25-0.45	 g/L	0.3	 	Ferritin	60	microg/L	6-137	 	Homocystein	44	micromol/L	&lt; 15	 	Bilirubin				 	</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4943</offset><text>Because high LDH and pancytopenia may be signs of myelodysplastic syndrome and leukemia, the bone marrow was examined. The bone marrow contained an increase in erythroblasts, but no other abnormalities.</text><annotation id="14140"><infon key="identifier">MESH:D010198</infon><infon key="type">Disease</infon><location offset="4964" length="12" /><text>pancytopenia</text></annotation><annotation id="14141"><infon key="identifier">MESH:D007938</infon><infon key="type">Disease</infon><location offset="5022" length="8" /><text>leukemia</text></annotation><annotation id="14142"><infon key="identifier">MESH:D009190</infon><infon key="type">Disease</infon><location offset="4993" length="24" /><text>myelodysplastic syndrome</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5146</offset><text>Urinalysis revealed proteinuria (1.04 g/L, normal range: &lt;0.12). Due to the combination of megaloblastic anemia, vitB12 deficiency and proteinuria, screening for abnormalities in the AMN and CUBN gene was performed. A homozygous variant in AMN, c.208-2 A &gt; G, was identified. The variant was previously reported in the literature and considered pathogenic.</text><annotation id="14143"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="5337" length="4" /><text>CUBN</text></annotation><annotation id="14144"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="5386" length="3" /><text>AMN</text></annotation><annotation id="14145"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="5329" length="3" /><text>AMN</text></annotation><annotation id="14147"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="5166" length="11" /><text>proteinuria</text></annotation><annotation id="14148"><infon key="identifier">tmVar:c|SUB|A|208-2|G;HGVS:c.208-2A&gt;G;VariantGroup:4;CorrespondingGene:81693;RS#:386834170(Expired);CorrespondingSpecies:9606;CA#:144409</infon><infon key="type">DNAMutation</infon><location offset="5391" length="13" /><text>c.208-2 A &gt; G</text></annotation><annotation id="14149"><infon key="identifier">MESH:D000749</infon><infon key="type">Disease</infon><location offset="5237" length="20" /><text>megaloblastic anemia</text></annotation><annotation id="14150"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="5281" length="11" /><text>proteinuria</text></annotation><annotation id="14151"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="5259" length="17" /><text>vitB12 deficiency</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5509</offset><text>Oral supplementation with vitB12 was initiated, correcting the vitB12 deficiency, anemia, and related symptoms.</text><annotation id="14152"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="5572" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14153"><infon key="identifier">MESH:D000740</infon><infon key="type">Disease</infon><location offset="5591" length="6" /><text>anemia</text></annotation><annotation id="14154"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="5535" length="6" /><text>vitB12</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5621</offset><text>The brother of patient 1 was tested for IGS and the same homozygous pathogenic variant c.208-2 A &gt; G mutation in AMN was detected at 8 months of age, in addition to the homozygous partial deletion of CYP21A2. He had an adrenal crisis at the age of 12 days, for which resuscitation and therapeutic hypothermia had been necessary. He was treated with steroids. At the age of 18 months, he was suffering from proteinuria and low levels of vitB12, without anemia or other clinical manifestations. Oral supplementation of vitB12 (cyanocobalamin 1 mg daily) was started, and vitB12 deficiency was corrected.</text><annotation id="14155"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="5734" length="3" /><text>AMN</text></annotation><annotation id="14156"><infon key="identifier">1589</infon><infon key="type">Gene</infon><location offset="5821" length="7" /><text>CYP21A2</text></annotation><annotation id="14157"><infon key="identifier">MESH:D000310</infon><infon key="type">Disease</infon><location offset="5840" length="14" /><text>adrenal crisis</text></annotation><annotation id="14158"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5636" length="7" /><text>patient</text></annotation><annotation id="14159"><infon key="identifier">MESH:D007035</infon><infon key="type">Disease</infon><location offset="5918" length="11" /><text>hypothermia</text></annotation><annotation id="14160"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="6027" length="11" /><text>proteinuria</text></annotation><annotation id="14161"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="6146" length="14" /><text>cyanocobalamin</text></annotation><annotation id="14162"><infon key="identifier">MESH:D000740</infon><infon key="type">Disease</infon><location offset="6073" length="6" /><text>anemia</text></annotation><annotation id="14163"><infon key="identifier">tmVar:c|SUB|A|208-2|G;HGVS:c.208-2A&gt;G;VariantGroup:4;CorrespondingGene:81693;RS#:386834170(Expired);CorrespondingSpecies:9606;CA#:144409</infon><infon key="type">DNAMutation</infon><location offset="5708" length="13" /><text>c.208-2 A &gt; G</text></annotation><annotation id="14164"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="6138" length="6" /><text>vitB12</text></annotation><annotation id="14165"><infon key="identifier">MESH:D013256</infon><infon key="type">Chemical</infon><location offset="5970" length="8" /><text>steroids</text></annotation><annotation id="14166"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="6190" length="6" /><text>vitB12</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6229</offset><text>We describe two siblings with IGS, who presented with vitamin B12 deficiency and proteinuria. The rare occurrence of this syndrome motivated us to provide an overview of all previously published cases and to discuss all aspects of IGS.</text><annotation id="14167"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="6283" length="22" /><text>vitamin B12 deficiency</text></annotation><annotation id="14168"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="6310" length="11" /><text>proteinuria</text></annotation><annotation id="14169"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="6259" length="3" /><text>IGS</text></annotation><annotation id="14170"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="6460" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6465</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6487</offset><text>Inclusion criteria</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6506</offset><text>This is a retrospective study with no restriction on the publication date or language. The data were gathered using a Pubmed and Google Scholar search, using the keywords "Imerslund-Grasbeck" and/or "Imerslund Grasbeck". All relevant articles, such as case reports, case series, and reviews, were reviewed. Additional cases were identified by consulting cited references of the identified articles. The included articles were selected based on title and abstract.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6978</offset><text>Data collection</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6994</offset><text>The following data were collected, if available: gender, consanguinity, origin, mutation analysis, age at onset and diagnosis, clinical manifestations at onset and diagnosis, laboratory examination (presence of pernicious anemia, vitB12 deficiency, proteinuria, Schilling tests, IF), examination of the renal system (including kidney biopsy and/or imaging, if applicable) and treatment. If the molecular analysis was not performed, information on IF analysis was included.</text><annotation id="14171"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="7243" length="11" /><text>proteinuria</text></annotation><annotation id="14172"><infon key="identifier">MESH:D000752</infon><infon key="type">Disease</infon><location offset="7205" length="17" /><text>pernicious anemia</text></annotation><annotation id="14173"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="7224" length="17" /><text>vitB12 deficiency</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7467</offset><text>Statistical analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7488</offset><text>We used descriptive statistics to summarize the data.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>7542</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7550</offset><text>Demographics</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7563</offset><text>In total, 111 articles were included. 22 additional articles were not accessible. A total of 456 patients were included, of which 2 were described in this report.</text><annotation id="14174"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="7660" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7726</offset><text>Origin</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7733</offset><text>In 349/456 patients, ethnicity was documented. 22% were Turkish, 15% Finnish, 7% Norwegian, 6% Tunisian, 5% Bedouin and 6% were from the United States of America. All other origins occurred in less than 3%. Consanguinity of the parents was reported in 160/456 patients, of which 73% were consanguineous.</text><annotation id="14175"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="7993" length="8" /><text>patients</text></annotation><annotation id="14176"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="7744" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8037</offset><text>Gender</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8044</offset><text>Gender was reported in 278/456 patients of which 55% were male and 45% female.</text><annotation id="14177"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="8075" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8123</offset><text>Age</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8127</offset><text>The median age of onset of the symptoms was 2,3 years old (mean 4,2, SD +- 5,3 years, ranging from 0 months to 38 years old). The median age at diagnosis was 7,2 years old (mean 7,7, SD +- 7,9 years, range from 8 months to 48 years old).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8365</offset><text>Gene and mutation analysis</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8392</offset><text>The genetic analysis had been performed in 252/456 patients, 49% had a genetic variation in AMN and 51% in CUBN. In total, 119 different homozygous and compound heterozygous variants were detected, of which 34 were in AMN and 85 were in CUBN.</text><annotation id="14178"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="8610" length="3" /><text>AMN</text></annotation><annotation id="14179"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="8484" length="3" /><text>AMN</text></annotation><annotation id="14180"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="8629" length="4" /><text>CUBN</text></annotation><annotation id="14181"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="8499" length="4" /><text>CUBN</text></annotation><annotation id="14185"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="8443" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8635</offset><text>The most common variants in AMN were c.208-2 A &gt; G (n = 78), c.14del6 (n = 22), c.1006 + 34_48del15bp (n = 18).</text><annotation id="14187"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="8663" length="3" /><text>AMN</text></annotation><annotation id="14188"><infon key="identifier">tmVar:c|DEL|14|6;HGVS:c.14del6;VariantGroup:5;CorrespondingGene:81693;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="8696" length="8" /><text>c.14del6</text></annotation><annotation id="14189"><infon key="identifier">tmVar:c|DEL|1006+34_48|15;HGVS:c.1006+34_48del15;VariantGroup:10;CorrespondingGene:81693;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="8715" length="21" /><text>c.1006 + 34_48del15bp</text></annotation><annotation id="14191"><infon key="identifier">tmVar:c|SUB|A|208-2|G;HGVS:c.208-2A&gt;G;VariantGroup:4;CorrespondingGene:81693;RS#:386834170(Expired);CorrespondingSpecies:9606;CA#:144409</infon><infon key="type">DNAMutation</infon><location offset="8672" length="13" /><text>c.208-2 A &gt; G</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8768</offset><text>The most common CUBN mutations were c.3890 C &gt; T (n = 36), c.434G &gt; A (n = 22), c.2614_2615delGA (n = 14) and c.9053 A &gt; C (n = 14).</text><annotation id="14192"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="8784" length="4" /><text>CUBN</text></annotation><annotation id="14193"><infon key="identifier">tmVar:c|SUB|A|9053|C;HGVS:c.9053A&gt;C;VariantGroup:1;CorrespondingGene:8029;RS#:370778353;CorrespondingSpecies:9606;CA#:5422829</infon><infon key="type">DNAMutation</infon><location offset="8878" length="12" /><text>c.9053 A &gt; C</text></annotation><annotation id="14194"><infon key="identifier">tmVar:c|SUB|C|3890|T;HGVS:c.3890C&gt;T;VariantGroup:3;CorrespondingGene:8029;RS#:121434430;CorrespondingSpecies:9606;CA#:118423</infon><infon key="type">DNAMutation</infon><location offset="8804" length="12" /><text>c.3890 C &gt; T</text></annotation><annotation id="14195"><infon key="identifier">tmVar:c|SUB|G|434|A;HGVS:c.434G&gt;A;VariantGroup:0;CorrespondingGene:8029;RS#:386833788(Expired);CorrespondingSpecies:9606;CA#:144296</infon><infon key="type">DNAMutation</infon><location offset="8827" length="10" /><text>c.434G &gt; A</text></annotation><annotation id="14196"><infon key="identifier">tmVar:c|DEL|2614_2615|GA;HGVS:c.2614_2615delGA;VariantGroup:2;CorrespondingGene:8029;RS#:386833777(Expired);CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="8848" length="16" /><text>c.2614_2615delGA</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8931</offset><text>Diagnosis</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8941</offset><text>In 52% of cases (235/456 patients), the diagnosis of IGS was confirmed by genetic analysis. In 22% (99/456 patients) the diagnosis was confirmed using a Schilling test and in 2% (9/456 patients), the diagnosis of the patient was suspected due to negative IF antibodies.</text><annotation id="14197"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9126" length="8" /><text>patients</text></annotation><annotation id="14198"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="8994" length="3" /><text>IGS</text></annotation><annotation id="14199"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="8966" length="8" /><text>patients</text></annotation><annotation id="14200"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9048" length="8" /><text>patients</text></annotation><annotation id="14201"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9158" length="7" /><text>patient</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>9211</offset><text>Clinical manifestations</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9235</offset><text>Information on clinical manifestations before diagnosis was provided in 325 of 456 patients (71%).</text><annotation id="14202"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9318" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9334</offset><text>Gastrointestinal manifestations occurred in 103 patients (32%), including non-specific symptoms (diarrhea, vomiting, failure to thrive, n = 67, 51%), hepato(spleno)megaly (n = 38, 37%), and jaundice (n = 6, 6%). Mucosal lesions in the mouth, such as a sore tongue, recurrent oral ulcers and gingivitis were present in 54/325 patients (17%).</text><annotation id="14203"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9659" length="8" /><text>patients</text></annotation><annotation id="14204"><infon key="identifier">MESH:D019226</infon><infon key="type">Disease</infon><location offset="9609" length="11" /><text>oral ulcers</text></annotation><annotation id="14205"><infon key="identifier">MESH:D009059</infon><infon key="type">Disease</infon><location offset="9546" length="28" /><text>Mucosal lesions in the mouth</text></annotation><annotation id="14206"><infon key="identifier">MESH:D014060</infon><infon key="type">Disease</infon><location offset="9586" length="11" /><text>sore tongue</text></annotation><annotation id="14207"><infon key="identifier">MESH:D014839</infon><infon key="type">Disease</infon><location offset="9441" length="8" /><text>vomiting</text></annotation><annotation id="14208"><infon key="identifier">MESH:D007565</infon><infon key="type">Disease</infon><location offset="9524" length="8" /><text>jaundice</text></annotation><annotation id="14209"><infon key="identifier">MESH:D003967</infon><infon key="type">Disease</infon><location offset="9431" length="8" /><text>diarrhea</text></annotation><annotation id="14210"><infon key="identifier">MESH:D005183</infon><infon key="type">Disease</infon><location offset="9451" length="17" /><text>failure to thrive</text></annotation><annotation id="14211"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9382" length="8" /><text>patients</text></annotation><annotation id="14212"><infon key="type">Disease</infon><location offset="9498" length="6" /><text>megaly</text></annotation><annotation id="14213"><infon key="identifier">MESH:D005891</infon><infon key="type">Disease</infon><location offset="9625" length="10" /><text>gingivitis</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9687</offset><text>Respiratory symptoms were present in 9/325 (3%) patients, including recurrent respiratory infection, bronchopneumonia, and exertional dyspnea. Other symptoms included hypopigmented hair in 6 patients (1.8%) and local skin hyperpigmentation (n = 5, 1.5%). Other symptoms were present in only 1 or 2 patients (Additional file 1).</text><annotation id="14214"><infon key="identifier">MESH:D004417</infon><infon key="type">Disease</infon><location offset="9821" length="7" /><text>dyspnea</text></annotation><annotation id="14215"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9985" length="8" /><text>patients</text></annotation><annotation id="14216"><infon key="identifier">MESH:D001996</infon><infon key="type">Disease</infon><location offset="9788" length="16" /><text>bronchopneumonia</text></annotation><annotation id="14217"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9878" length="8" /><text>patients</text></annotation><annotation id="14218"><infon key="identifier">MESH:D017495</infon><infon key="type">Disease</infon><location offset="9904" length="22" /><text>skin hyperpigmentation</text></annotation><annotation id="14219"><infon key="identifier">MESH:D006201</infon><infon key="type">Disease</infon><location offset="9854" length="18" /><text>hypopigmented hair</text></annotation><annotation id="14220"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="9735" length="8" /><text>patients</text></annotation><annotation id="14221"><infon key="identifier">MESH:D012141</infon><infon key="type">Disease</infon><location offset="9765" length="21" /><text>respiratory infection</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10019</offset><text>Neurological manifestations were observed in 52 patients (16%). Most frequently, patients showed lethargy (n = 13, 25%), ataxia (n = 10, 19%), and motor or sensory deficits (n = 7, 13%). More severe clinical manifestations were present in 4% of IGS patients, which included funicular myelosis (subacute combined degeneration of the cord, n = 5, 10%), seizures (n = 3, 6%), focal cortical atrophy of the left insular region on MRI (n = 2; 3.8%) and progressive dementia (n = 1, 2%). For the other neurological manifestations, we refer to Additional file 1.</text><annotation id="14222"><infon key="identifier">MESH:D001289</infon><infon key="type">Disease</infon><location offset="10166" length="25" /><text>motor or sensory deficits</text></annotation><annotation id="14223"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10100" length="8" /><text>patients</text></annotation><annotation id="14224"><infon key="identifier">MESH:D053609</infon><infon key="type">Disease</infon><location offset="10116" length="8" /><text>lethargy</text></annotation><annotation id="14225"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10268" length="8" /><text>patients</text></annotation><annotation id="14226"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="10479" length="8" /><text>dementia</text></annotation><annotation id="14227"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="10370" length="8" /><text>seizures</text></annotation><annotation id="14228"><infon key="identifier">MESH:D055728</infon><infon key="type">Disease</infon><location offset="10303" length="8" /><text>myelosis</text></annotation><annotation id="14229"><infon key="identifier">MESH:D001259</infon><infon key="type">Disease</infon><location offset="10140" length="6" /><text>ataxia</text></annotation><annotation id="14230"><infon key="identifier">MESH:D009410</infon><infon key="type">Disease</infon><location offset="10331" length="24" /><text>degeneration of the cord</text></annotation><annotation id="14231"><infon key="identifier">MESH:D001284</infon><infon key="type">Disease</infon><location offset="10407" length="7" /><text>atrophy</text></annotation><annotation id="14232"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10067" length="8" /><text>patients</text></annotation><annotation id="14233"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="10264" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10603</offset><text>In 247 patients, vitB12 levels were described, which were decreased in 94% of the patients. 89% of these patients had pernicious anemia.</text><annotation id="14234"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10685" length="8" /><text>patients</text></annotation><annotation id="14235"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10610" length="8" /><text>patients</text></annotation><annotation id="14236"><infon key="identifier">MESH:D000752</infon><infon key="type">Disease</infon><location offset="10721" length="17" /><text>pernicious anemia</text></annotation><annotation id="14237"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10708" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10740</offset><text>In 239/456 patients, urinalysis was documented. Of these patients, 212 (89%) had proteinuria. Only in Finland, the fraction of patients with proteinuria was lower than in other countries (20% had proteinuria, 18% had no proteinuria, 62% had no urinalysis).</text><annotation id="14238"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="10936" length="11" /><text>proteinuria</text></annotation><annotation id="14239"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="10821" length="11" /><text>proteinuria</text></annotation><annotation id="14240"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10797" length="8" /><text>patients</text></annotation><annotation id="14241"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="10960" length="11" /><text>proteinuria</text></annotation><annotation id="14242"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10867" length="8" /><text>patients</text></annotation><annotation id="14243"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10751" length="8" /><text>patients</text></annotation><annotation id="14244"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="10881" length="11" /><text>proteinuria</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>10997</offset><text>Comorbidities</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11011</offset><text>Of the 325 patients with reported clinical circumstances, 48 (15%) had associated comorbidities in addition to IGS (Table 2). Abnormalities in the urogenital tract were most often observed, which included anatomic nephrogenic or urinary tract abnormalities (n = 10, 3%) and vesicoureteral reflux or IgA nephropathy (both n = 1, 0.3%).</text><annotation id="14245"><infon key="identifier">MESH:D014570</infon><infon key="type">Disease</infon><location offset="11225" length="42" /><text>nephrogenic or urinary tract abnormalities</text></annotation><annotation id="14246"><infon key="identifier">MESH:D014718</infon><infon key="type">Disease</infon><location offset="11285" length="21" /><text>vesicoureteral reflux</text></annotation><annotation id="14247"><infon key="identifier">MESH:D005922</infon><infon key="type">Disease</infon><location offset="11310" length="15" /><text>IgA nephropathy</text></annotation><annotation id="14248"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11022" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="type">table_caption</infon><offset>11355</offset><text>Comorbidities in IGS patients, expressed in number of patients n and percentage % (of the total amount of patients in which clinical characteristics were described in the article; 325 patients)</text><annotation id="14249"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11461" length="8" /><text>patients</text></annotation><annotation id="14250"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11409" length="8" /><text>patients</text></annotation><annotation id="14251"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11539" length="8" /><text>patients</text></annotation><annotation id="14252"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="11372" length="3" /><text>IGS</text></annotation><annotation id="14253"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11376" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">Tab2.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align="left"&gt; &lt;italic&gt;Comorbidity&lt;/italic&gt; &lt;/th&gt;&lt;th align="left"&gt; &lt;italic&gt;n&lt;/italic&gt; &lt;/th&gt;&lt;th align="left"&gt;%&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;bold&gt;Urinary tract&lt;/bold&gt; &lt;/td&gt;&lt;td char="." align="char"&gt;18&lt;/td&gt;&lt;td align="left"&gt;5.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Anatomical urinary tract anomalies&lt;/td&gt;&lt;td char="." align="char"&gt;10&lt;/td&gt;&lt;td align="left"&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Alport syndrome&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Focal segmental glomerulosclerosis&lt;/td&gt;&lt;td char="." align="char"&gt;4&lt;/td&gt;&lt;td align="left"&gt;1.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;IgA nephropathy grade I&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Membranous glomerulonephritis&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Vesico-urethral reflux grade II&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;bold&gt;Haematological&lt;/bold&gt; &lt;/td&gt;&lt;td char="." align="char"&gt;11&lt;/td&gt;&lt;td align="left"&gt;3.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Alpha thalassemia&lt;/td&gt;&lt;td char="." align="char"&gt;2&lt;/td&gt;&lt;td align="left"&gt;0.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Alpha thalassemia trait&lt;/td&gt;&lt;td char="." align="char"&gt;2&lt;/td&gt;&lt;td align="left"&gt;0.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Beta thalassemia&lt;/td&gt;&lt;td char="." align="char"&gt;2&lt;/td&gt;&lt;td align="left"&gt;0.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Beta thalassemia trait&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Defective neutrophil function&lt;/td&gt;&lt;td char="." align="char"&gt;3&lt;/td&gt;&lt;td align="left"&gt;0.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Sickle anemia&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;bold&gt;Immunological/endocrine disorders&lt;/bold&gt; &lt;/td&gt;&lt;td char="." align="char"&gt;11&lt;/td&gt;&lt;td align="left"&gt;3.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Congenital adrenal hyperplasia&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Congenital hypothyroidy&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Eosinophilic enterocolitis&lt;/td&gt;&lt;td char="." align="char"&gt;2&lt;/td&gt;&lt;td align="left"&gt;0.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Fanconi anemia&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Gluten intolerance&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;IgA deficiency&lt;/td&gt;&lt;td char="." align="char"&gt;3&lt;/td&gt;&lt;td align="left"&gt;0.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Type I diabetes&lt;/td&gt;&lt;td char="." align="char"&gt;2&lt;/td&gt;&lt;td align="left"&gt;0.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;bold&gt;Ophthalmological abnormalities&lt;/bold&gt; &lt;/td&gt;&lt;td char="." align="char"&gt;3&lt;/td&gt;&lt;td align="left"&gt;0.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Cataract&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Partial atrophy of optic nerves&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Congenital retinal atrophy&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt; &lt;bold&gt;Other&lt;/bold&gt; &lt;/td&gt;&lt;td char="." align="char"&gt;10&lt;/td&gt;&lt;td align="left"&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Gastroschisis&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Prematurity&lt;/td&gt;&lt;td char="." align="char"&gt;3&lt;/td&gt;&lt;td align="left"&gt;0.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Pulmonary tuberculosis&lt;/td&gt;&lt;td char="." align="char"&gt;2&lt;/td&gt;&lt;td align="left"&gt;0.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Rectal polyp&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Right-side heart failure&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Trisomy 21&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Thrombotic microangiopathy&lt;/td&gt;&lt;td char="." align="char"&gt;1&lt;/td&gt;&lt;td align="left"&gt;0.3&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">Tab2</infon><infon key="type">table</infon><offset>11549</offset><text>Comorbidity	n	%	 	Urinary tract	18	5.5	 	Anatomical urinary tract anomalies	10	3	 	Alport syndrome	1	0.3	 	Focal segmental glomerulosclerosis	4	1.2	 	IgA nephropathy grade I	1	0.3	 	Membranous glomerulonephritis	1	0.3	 	Vesico-urethral reflux grade II	1	0.3	 	Haematological	11	3.4	 	Alpha thalassemia	2	0.6	 	Alpha thalassemia trait	2	0.6	 	Beta thalassemia	2	0.6	 	Beta thalassemia trait	1	0.3	 	Defective neutrophil function	3	0.9	 	Sickle anemia	1	0.3	 	Immunological/endocrine disorders	11	3.4	 	Congenital adrenal hyperplasia	1	0.3	 	Congenital hypothyroidy	1	0.3	 	Eosinophilic enterocolitis	2	0.6	 	Fanconi anemia	1	0.3	 	Gluten intolerance	1	0.3	 	IgA deficiency	3	0.9	 	Type I diabetes	2	0.6	 	Ophthalmological abnormalities	3	0.9	 	Cataract	1	0.3	 	Partial atrophy of optic nerves	1	0.3	 	Congenital retinal atrophy	1	0.3	 	Other	10	3	 	Gastroschisis	1	0.3	 	Prematurity	3	0.9	 	Pulmonary tuberculosis	2	0.6	 	Rectal polyp	1	0.3	 	Right-side heart failure	1	0.3	 	Trisomy 21	1	0.3	 	Thrombotic microangiopathy	1	0.3	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12581</offset><text>In 19 patients, a kidney biopsy was performed. Most patients exhibited glomerular abnormalities (n = 17, 5.2% of 325 patients) including 4 cases of focal segmental glomerulosclerosis. Some patients exhibited tubular abnormalities (n = 2, 0.6% of 325 patients). No deterioration of kidney function has been reported in any IGS patients, to the authors' knowledge.</text><annotation id="14254"><infon key="identifier">MESH:D000230</infon><infon key="type">Disease</infon><location offset="12789" length="21" /><text>tubular abnormalities</text></annotation><annotation id="14255"><infon key="identifier">MESH:D007674</infon><infon key="type">Disease</infon><location offset="12652" length="24" /><text>glomerular abnormalities</text></annotation><annotation id="14256"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12770" length="8" /><text>patients</text></annotation><annotation id="14257"><infon key="identifier">MESH:D058186</infon><infon key="type">Disease</infon><location offset="12845" length="32" /><text>deterioration of kidney function</text></annotation><annotation id="14258"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12831" length="8" /><text>patients</text></annotation><annotation id="14259"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12698" length="8" /><text>patients</text></annotation><annotation id="14260"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12907" length="8" /><text>patients</text></annotation><annotation id="14261"><infon key="identifier">MESH:D005923</infon><infon key="type">Disease</infon><location offset="12729" length="34" /><text>focal segmental glomerulosclerosis</text></annotation><annotation id="14262"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="12903" length="3" /><text>IGS</text></annotation><annotation id="14263"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12633" length="8" /><text>patients</text></annotation><annotation id="14264"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12587" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12954</offset><text>The other most common comorbidities were thalassemia (n = 7, 2.2%), IgA deficiency and defective neutrophil function (both n = 3, 0.9%). Other comorbidities occurred in only 1 or 2 patients.</text><annotation id="14265"><infon key="identifier">MESH:D013789</infon><infon key="type">Disease</infon><location offset="12995" length="11" /><text>thalassemia</text></annotation><annotation id="14266"><infon key="identifier">MESH:D017098</infon><infon key="type">Disease</infon><location offset="13022" length="14" /><text>IgA deficiency</text></annotation><annotation id="14267"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="13135" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13153</offset><text>Therapy</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13161</offset><text>The method of vitB12 therapy was described in 240/456 cases. VitB12 was administered intramuscularly in 88%, parenteral (either intravenous or intramuscular, but not further specified) in 2%, and orally in 9% (including in our patients).</text><annotation id="14268"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="13175" length="6" /><text>vitB12</text></annotation><annotation id="14269"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="13222" length="6" /><text>VitB12</text></annotation><annotation id="14270"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="13388" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>13399</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>13410</offset><text>Vitamin B12 physiology</text><annotation id="14271"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="13410" length="11" /><text>Vitamin B12</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13433</offset><text>VitB12 is a water-soluble vitamin most commonly found in animal products. It serves as a cofactor for enzymes involved in metabolism. Upon entry into the stomach, vitB12 is released from dietary proteins and bound to haptocorrin. The complex consisting of vitB12 and haptocorrin is broken down in the intestine and a complex consisting of vitB12 and IF is formed. In the terminal ileum, it binds to the cubam receptor located on the ileal apical brush border, and the cubam complex is internalized by endocytosis. In the endosome, the IF-vitB12 complex is released from the cubam receptor. VitB12 is released from IF in the lysosome and exported to blood. In the blood, it is transported bound by transcobalamin II, which also enables vitB12 to enter target cells. In the target cells, vitB12 is released into the lysosome, enabling it to serve as a cofactor in metabolic processes. VitB12 deficiency can lead to the deficiency of the cofactors adenosylcobalamin and methylcobalamin. Adenosylcobalamin is a cofactor of the enzyme methylmalonyl-coenzyme A mutase which enables the degradation of methylmalonyl-CoA into succinyl-CoA, which is a Kreb cycle intermediate. This is the final step in the degradation of the aminoacids isoleucine/valine/threonine and odd-chain fatty acids. Methylcobalamin is a cofactor of methionine synthase, which is responsible for converting homocysteine into methionine. Methionine is then converted to S-adenosylmethionine, which is essential for the methylation of several compounds such as creatine, epinephrine, DNA, RNA and proteins.</text><annotation id="14272"><infon key="identifier">6947</infon><infon key="type">Gene</infon><location offset="13650" length="11" /><text>haptocorrin</text></annotation><annotation id="14273"><infon key="identifier">6947</infon><infon key="type">Gene</infon><location offset="13700" length="11" /><text>haptocorrin</text></annotation><annotation id="14274"><infon key="identifier">6948</infon><infon key="type">Gene</infon><location offset="14130" length="17" /><text>transcobalamin II</text></annotation><annotation id="14275"><infon key="identifier">4594</infon><infon key="type">Gene</infon><location offset="14463" length="31" /><text>methylmalonyl-coenzyme A mutase</text></annotation><annotation id="14276"><infon key="identifier">4548</infon><infon key="type">Gene</infon><location offset="14749" length="19" /><text>methionine synthase</text></annotation><annotation id="14277"><infon key="identifier">tmVar:p|SUB|I||V;VariantGroup:12;CorrespondingGene:4594;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="14661" length="17" /><text>isoleucine/valine</text></annotation><annotation id="14278"><infon key="identifier">MESH:C000913</infon><infon key="type">Chemical</infon><location offset="14378" length="17" /><text>adenosylcobalamin</text></annotation><annotation id="14279"><infon key="identifier">MESH:D003401</infon><infon key="type">Chemical</infon><location offset="14958" length="8" /><text>creatine</text></annotation><annotation id="14280"><infon key="identifier">MESH:D006710</infon><infon key="type">Chemical</infon><location offset="14806" length="12" /><text>homocysteine</text></annotation><annotation id="14281"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="14693" length="21" /><text>odd-chain fatty acids</text></annotation><annotation id="14282"><infon key="identifier">MESH:C015357</infon><infon key="type">Chemical</infon><location offset="14528" length="17" /><text>methylmalonyl-CoA</text></annotation><annotation id="14283"><infon key="identifier">MESH:D012436</infon><infon key="type">Chemical</infon><location offset="14868" length="20" /><text>S-adenosylmethionine</text></annotation><annotation id="14284"><infon key="identifier">MESH:D004837</infon><infon key="type">Chemical</infon><location offset="14968" length="11" /><text>epinephrine</text></annotation><annotation id="14285"><infon key="identifier">MESH:C019476</infon><infon key="type">Chemical</infon><location offset="14716" length="15" /><text>Methylcobalamin</text></annotation><annotation id="14286"><infon key="identifier">MESH:C012046</infon><infon key="type">Chemical</infon><location offset="14551" length="12" /><text>succinyl-CoA</text></annotation><annotation id="14287"><infon key="identifier">MESH:C019476</infon><infon key="type">Chemical</infon><location offset="14400" length="15" /><text>methylcobalamin</text></annotation><annotation id="14288"><infon key="identifier">MESH:D008715</infon><infon key="type">Chemical</infon><location offset="14836" length="10" /><text>Methionine</text></annotation><annotation id="14289"><infon key="identifier">MESH:C000913</infon><infon key="type">Chemical</infon><location offset="14417" length="17" /><text>Adenosylcobalamin</text></annotation><annotation id="14290"><infon key="identifier">MESH:D000596</infon><infon key="type">Chemical</infon><location offset="14650" length="10" /><text>aminoacids</text></annotation><annotation id="14292"><infon key="identifier">MESH:D014867</infon><infon key="type">Chemical</infon><location offset="13445" length="5" /><text>water</text></annotation><annotation id="14293"><infon key="identifier">MESH:D007153</infon><infon key="type">Disease</infon><location offset="14316" length="17" /><text>VitB12 deficiency</text></annotation><annotation id="14294"><infon key="identifier">MESH:D008715</infon><infon key="type">Chemical</infon><location offset="14824" length="10" /><text>methionine</text></annotation><annotation id="14295"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="14576" length="4" /><text>Kreb</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>15004</offset><text>Pathophysiology</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15020</offset><text>IGS is an autosomal recessive disorder caused by pathogenic variants in either CUBN or AMN, which encode the 2 subcomplexes of the cubam receptor: cubilin and amnionless. Cubilin is a large protein that can bind several ligands and is responsible for the uptake of vitB12, but also for renal tubular reabsorption of other proteins after glomerular ultrafiltration. As it has no transmembrane region, it is bound to the transmembrane protein amnionless, which also mediates internalization of the IF-vitB12-cubam complex.</text><annotation id="14296"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="15099" length="4" /><text>CUBN</text></annotation><annotation id="14297"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="15107" length="3" /><text>AMN</text></annotation><annotation id="14298"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="15167" length="7" /><text>cubilin</text></annotation><annotation id="14299"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="15179" length="10" /><text>amnionless</text></annotation><annotation id="14300"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="15191" length="7" /><text>Cubilin</text></annotation><annotation id="14301"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="15461" length="10" /><text>amnionless</text></annotation><annotation id="14302"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="15030" length="28" /><text>autosomal recessive disorder</text></annotation><annotation id="14303"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="15020" length="3" /><text>IGS</text></annotation><annotation id="14304"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="15285" length="6" /><text>vitB12</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15541</offset><text>It has been demonstrated that the binding of amnionless to cubilin occurs very early in its biogenesis. After that, cubilin undergoes a posttranslational modification in the endoplasmatic reticulum (ER), after which the complex is packed in the vesicles of the Golgi apparatus and transported to the plasma membrane. Studies have shown that cubilin and amnionless are mutually dependent on each other and that none of the two proteins can reach the plasma membrane if the other is deficient. Udagawa et al. described several mechanisms underlying impairment in renal and intestinal absorption in IGS patients. Variants in either CUBN or AMN caused defects in intracellular trafficking, accumulation in the ER and therefore decreased membrane expression in vitro. This was confirmed in vivo by a kidney biopsy of an IGS patient with a CUBN mutation. There was an expression of cubilin and amnionless in the ER of proximal tubular cells but not in the brush border of proximal tubular cells, where cubilin and amnionless should be present. Furthermore, AMN variants result in defective binding of cubilin to amnionless, which was not observed in CUBN variants. Finally, both AMN and CUBN variants cause disrupted glycosylation of cubilin. N-glycosylation is a posttranslational modification process that regulates protein folding, protein stability, protein complex formation and intracellular trafficking. Specific N-glycosylation in cubilin domains is be essential for cubam complex maturation and surface localization.</text><annotation id="14305"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="15586" length="10" /><text>amnionless</text></annotation><annotation id="14306"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="15600" length="7" /><text>cubilin</text></annotation><annotation id="14307"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="15657" length="7" /><text>cubilin</text></annotation><annotation id="14308"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="15882" length="7" /><text>cubilin</text></annotation><annotation id="14309"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16375" length="4" /><text>CUBN</text></annotation><annotation id="14310"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16417" length="7" /><text>cubilin</text></annotation><annotation id="14311"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="16429" length="10" /><text>amnionless</text></annotation><annotation id="14312"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16537" length="7" /><text>cubilin</text></annotation><annotation id="14313"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="16549" length="10" /><text>amnionless</text></annotation><annotation id="14314"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="16592" length="3" /><text>AMN</text></annotation><annotation id="14315"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16636" length="7" /><text>cubilin</text></annotation><annotation id="14316"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16685" length="4" /><text>CUBN</text></annotation><annotation id="14317"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="16714" length="3" /><text>AMN</text></annotation><annotation id="14318"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16722" length="4" /><text>CUBN</text></annotation><annotation id="14319"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16769" length="7" /><text>cubilin</text></annotation><annotation id="14320"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16974" length="7" /><text>cubilin</text></annotation><annotation id="14321"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="16178" length="3" /><text>AMN</text></annotation><annotation id="14322"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="16647" length="10" /><text>amnionless</text></annotation><annotation id="14323"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="15894" length="10" /><text>amnionless</text></annotation><annotation id="14324"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="16170" length="4" /><text>CUBN</text></annotation><annotation id="14326"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="16356" length="3" /><text>IGS</text></annotation><annotation id="14329"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="16360" length="7" /><text>patient</text></annotation><annotation id="14330"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="16137" length="3" /><text>IGS</text></annotation><annotation id="14331"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="16141" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>17061</offset><text>Clinical manifestations</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17085</offset><text>Patients may develop symptoms once fetal hepatic vitB12 is exhausted, generally between the ages of 1 and 5 years. Patients may present with non-specific symptoms such as failure to thrive, general weakness, and recurrent gastro-intestinal and/or respiratory infections. In addition to non-specific symptoms, we observed a relatively high amount of oral mucosal lesions in 17% of the patients. We did not observe any relations between these non-specific symptoms and genotype.</text><annotation id="14333"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="17200" length="8" /><text>Patients</text></annotation><annotation id="14334"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="17469" length="8" /><text>patients</text></annotation><annotation id="14335"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="17085" length="8" /><text>Patients</text></annotation><annotation id="14336"><infon key="identifier">MESH:D005183</infon><infon key="type">Disease</infon><location offset="17256" length="17" /><text>failure to thrive</text></annotation><annotation id="14337"><infon key="identifier">MESH:D009059</infon><infon key="type">Disease</infon><location offset="17434" length="20" /><text>oral mucosal lesions</text></annotation><annotation id="14338"><infon key="identifier">MESH:D012141</infon><infon key="type">Disease</infon><location offset="17307" length="47" /><text>gastro-intestinal and/or respiratory infections</text></annotation><annotation id="14339"><infon key="identifier">MESH:D018908</infon><infon key="type">Disease</infon><location offset="17283" length="8" /><text>weakness</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17562</offset><text>Neurocognitive symptoms have been attributed to several pathophysiological mechanisms, including decreased myelinization as a result of impaired methylation due to vitB12 shortage and the direct toxic effects of homocysteine and methylmalonic acid. Neurological symptoms are reported to be generally mild and non-specific such as developmental delay, learning difficulties, and psychological symptoms due to vitB12 deficiency. In our review, we observed a surprisingly high incidence of moderate (ataxia in 4% of IGS patients) and even severe neurological manifestations including patients with convulsions, degeneration of the spinal cord, focal cortical brain atrophy, and progressive dementia (3.5% of IGS patients). The numbers of these severe neurological manifestations were, however, too small to draw conclusions about phenotype-genotype correlations.</text><annotation id="14340"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="17811" length="21" /><text>Neurological symptoms</text></annotation><annotation id="14341"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="18249" length="8" /><text>dementia</text></annotation><annotation id="14342"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="18079" length="8" /><text>patients</text></annotation><annotation id="14343"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="18143" length="8" /><text>patients</text></annotation><annotation id="14344"><infon key="identifier">MESH:D012816</infon><infon key="type">Disease</infon><location offset="17562" length="23" /><text>Neurocognitive symptoms</text></annotation><annotation id="14345"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="18267" length="3" /><text>IGS</text></annotation><annotation id="14346"><infon key="identifier">MESH:C566985</infon><infon key="type">Disease</infon><location offset="18209" length="22" /><text>cortical brain atrophy</text></annotation><annotation id="14347"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="17892" length="19" /><text>developmental delay</text></annotation><annotation id="14348"><infon key="identifier">MESH:D013118</infon><infon key="type">Disease</infon><location offset="18170" length="31" /><text>degeneration of the spinal cord</text></annotation><annotation id="14349"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="18157" length="11" /><text>convulsions</text></annotation><annotation id="14350"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="17970" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14351"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="18271" length="8" /><text>patients</text></annotation><annotation id="14352"><infon key="identifier">MESH:D008764</infon><infon key="type">Chemical</infon><location offset="17791" length="18" /><text>methylmalonic acid</text></annotation><annotation id="14353"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="18075" length="3" /><text>IGS</text></annotation><annotation id="14354"><infon key="identifier">MESH:D007859</infon><infon key="type">Disease</infon><location offset="17913" length="21" /><text>learning difficulties</text></annotation><annotation id="14355"><infon key="identifier">MESH:D001259</infon><infon key="type">Disease</infon><location offset="18059" length="6" /><text>ataxia</text></annotation><annotation id="14356"><infon key="identifier">MESH:D006710</infon><infon key="type">Chemical</infon><location offset="17774" length="12" /><text>homocysteine</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>18422</offset><text>Proteinuria and renal manifestations</text><annotation id="14357"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="18422" length="11" /><text>Proteinuria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18459</offset><text>Proteins that are found in the urine are predominantly middle molecular weights proteins with a high fraction of albumin (61-100%). Aminoaciduria has been described by some authors. Only very small amounts of high molecular weight proteins, such as IgG, were found.</text><annotation id="14358"><infon key="identifier">213</infon><infon key="type">Gene</infon><location offset="18572" length="7" /><text>albumin</text></annotation><annotation id="14359"><infon key="identifier">MESH:D000608</infon><infon key="type">Disease</infon><location offset="18591" length="13" /><text>Aminoaciduria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18727</offset><text>The pathophysiology of proteinuria has not been fully elucidated. The proteinuria is not of the classical glomerular or tubular type, but probably results from the lack of cubilin function that is needed for tubular reabsorption of some, but not all, urinary proteins. Both cubilin and amnionless are highly expressed in the proximal tubules of the kidney. In the proximal tubule, but not in the intestine, they interact with the endocytic receptor megalin, which leads to the internalization of the cubilin-amnionless complex (cubam) and thus enables the reabsorption of filtered plasma proteins. In the case of a mutation in CUBN or AMN, retention of cubilin and amnionless in the ER of proximal tubular cells can occur, leading to the absence of cubam on the cell surface and deficient reabsorption of albumin in the proximal tubule, resulting in proteinuria. There have been some observations of tubular abnormalities in patients who had a kidney biopsy, including tubular atrophy and the presence of giant mitochondria in epithelial cells of the proximal tubule.</text><annotation id="14360"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="18899" length="7" /><text>cubilin</text></annotation><annotation id="14361"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="19001" length="7" /><text>cubilin</text></annotation><annotation id="14362"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="19013" length="10" /><text>amnionless</text></annotation><annotation id="14363"><infon key="identifier">4036</infon><infon key="type">Gene</infon><location offset="19176" length="7" /><text>megalin</text></annotation><annotation id="14364"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="19227" length="7" /><text>cubilin</text></annotation><annotation id="14365"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="19235" length="10" /><text>amnionless</text></annotation><annotation id="14366"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="19354" length="4" /><text>CUBN</text></annotation><annotation id="14367"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="19362" length="3" /><text>AMN</text></annotation><annotation id="14368"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="19380" length="7" /><text>cubilin</text></annotation><annotation id="14369"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="19392" length="10" /><text>amnionless</text></annotation><annotation id="14370"><infon key="identifier">213</infon><infon key="type">Gene</infon><location offset="19532" length="7" /><text>albumin</text></annotation><annotation id="14371"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="18797" length="11" /><text>proteinuria</text></annotation><annotation id="14372"><infon key="identifier">MESH:D001284</infon><infon key="type">Disease</infon><location offset="19696" length="15" /><text>tubular atrophy</text></annotation><annotation id="14373"><infon key="identifier">MESH:D000230</infon><infon key="type">Disease</infon><location offset="19627" length="21" /><text>tubular abnormalities</text></annotation><annotation id="14374"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="19577" length="11" /><text>proteinuria</text></annotation><annotation id="14375"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="19652" length="8" /><text>patients</text></annotation><annotation id="14376"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="18750" length="11" /><text>proteinuria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19795</offset><text>There is, however, also some evidence of a glomerular origin of proteinuria and several authors described glomerular abnormalities in patients who had a kidney biopsy. This included pathological changes in podocytes (cubilin is also expressed in podocytes), which may contribute to proteinuria. Evidence of focal segmental glomerulosclerosis with glomerular mesangial cell proliferation, interstitial fibrosis, and structural abnormalities of podocytes including effacement of foot processes and podocyte microvillation, has also been observed. Other authors have found similar abnormalities of slight chronic glomerulopathy or glomerulonephritis.</text><annotation id="14377"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="20012" length="7" /><text>cubilin</text></annotation><annotation id="14378"><infon key="identifier">MESH:D007674</infon><infon key="type">Disease</infon><location offset="19901" length="24" /><text>glomerular abnormalities</text></annotation><annotation id="14379"><infon key="identifier">MESH:D002908</infon><infon key="type">Disease</infon><location offset="20397" length="22" /><text>chronic glomerulopathy</text></annotation><annotation id="14380"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="19859" length="11" /><text>proteinuria</text></annotation><annotation id="14381"><infon key="identifier">MESH:D005923</infon><infon key="type">Disease</infon><location offset="20102" length="34" /><text>focal segmental glomerulosclerosis</text></annotation><annotation id="14382"><infon key="identifier">MESH:D005355</infon><infon key="type">Disease</infon><location offset="20183" length="21" /><text>interstitial fibrosis</text></annotation><annotation id="14383"><infon key="identifier">MESH:D005921</infon><infon key="type">Disease</infon><location offset="20423" length="18" /><text>glomerulonephritis</text></annotation><annotation id="14384"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="19929" length="8" /><text>patients</text></annotation><annotation id="14385"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="20077" length="11" /><text>proteinuria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20443</offset><text>The pathophysiology of these renal manifestations remains poorly understood. The involvement of megalin, has been suggested in the pathophysiology of renal abnormalities. Megalin can bind albumin, while cubilin is thought to have a higher binding affinity to albumin as compared to megalin. Some authors hypothesized that in the absence of normal cubilin, a higher amount of albumin is bound to megalin, promoting a pathological cascade resulting in podocyte apoptosis via the PI-3 K/PKB pathway, resulting in changes in glomerular basement membrane abnormalities and focal segmental glomerulosclerosis.</text><annotation id="14386"><infon key="identifier">4036</infon><infon key="type">Gene</infon><location offset="20539" length="7" /><text>megalin</text></annotation><annotation id="14387"><infon key="identifier">4036</infon><infon key="type">Gene</infon><location offset="20614" length="7" /><text>Megalin</text></annotation><annotation id="14388"><infon key="identifier">213</infon><infon key="type">Gene</infon><location offset="20631" length="7" /><text>albumin</text></annotation><annotation id="14389"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="20646" length="7" /><text>cubilin</text></annotation><annotation id="14390"><infon key="identifier">213</infon><infon key="type">Gene</infon><location offset="20702" length="7" /><text>albumin</text></annotation><annotation id="14391"><infon key="identifier">4036</infon><infon key="type">Gene</infon><location offset="20725" length="7" /><text>megalin</text></annotation><annotation id="14392"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="20790" length="7" /><text>cubilin</text></annotation><annotation id="14393"><infon key="identifier">213</infon><infon key="type">Gene</infon><location offset="20818" length="7" /><text>albumin</text></annotation><annotation id="14394"><infon key="identifier">4036</infon><infon key="type">Gene</infon><location offset="20838" length="7" /><text>megalin</text></annotation><annotation id="14395"><infon key="identifier">5293</infon><infon key="type">Gene</infon><location offset="20920" length="6" /><text>PI-3 K</text></annotation><annotation id="14396"><infon key="identifier">2185</infon><infon key="type">Gene</infon><location offset="20927" length="3" /><text>PKB</text></annotation><annotation id="14397"><infon key="identifier">MESH:D007674</infon><infon key="type">Disease</infon><location offset="20593" length="19" /><text>renal abnormalities</text></annotation><annotation id="14398"><infon key="identifier">MESH:D019867</infon><infon key="type">Disease</infon><location offset="20964" length="42" /><text>glomerular basement membrane abnormalities</text></annotation><annotation id="14399"><infon key="identifier">MESH:D005923</infon><infon key="type">Disease</infon><location offset="21011" length="34" /><text>focal segmental glomerulosclerosis</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21048</offset><text>Kidney biopsy has been performed only rarely, because in the last years, it has become clear that although proteinuria persists, renal abnormalities do not progress in IGS patients that are treated with vitB12 1. The reason for this observation is unknown, but it has been suggested that unlike proteinuria, there may be small changes in kidney ultrastructure that respond to vitB12 supplementation.</text><annotation id="14400"><infon key="identifier">MESH:D007674</infon><infon key="type">Disease</infon><location offset="21177" length="19" /><text>renal abnormalities</text></annotation><annotation id="14401"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="21424" length="6" /><text>vitB12</text></annotation><annotation id="14402"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="21343" length="11" /><text>proteinuria</text></annotation><annotation id="14403"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="21216" length="3" /><text>IGS</text></annotation><annotation id="14404"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21220" length="8" /><text>patients</text></annotation><annotation id="14405"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="21155" length="11" /><text>proteinuria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21448</offset><text>In our series, 89% of IGS patients had proteinuria. Smaller numbers have been reported earlier [, but these were small series within one region. There are several reasons for overestimation.</text><annotation id="14406"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="21470" length="3" /><text>IGS</text></annotation><annotation id="14407"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21474" length="8" /><text>patients</text></annotation><annotation id="14408"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="21487" length="11" /><text>proteinuria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21639</offset><text>Firstly, urinanalysis was documented in 232 patients, but clinical features were documented in 325 patients. It may be possible that 89% proteinuria is an overestimation and that the number of patients with proteinuria may be closer to 62% (203 patients with proteinuria among 325 patients in which clinical characteristics were described). Secondly, given that only 92 of those patients had genetically confirmed IGS (40%), some of the patients may strictly not be IGS. However, due to the combination of vitB12 deficiency and proteinuria, IGS is very likely. Thirdly, there may be an overestimation because patients without proteinuria may not all be diagnosed. A combination of vitB12 deficiency and proteinuria prompts further diagnostic testing for IGS. An absence of proteinuria, however, may not lead to diagnostic testing for IGS. Fourthly, we observed that Finnish patients less frequently exhibited proteinuria. As Finland is one of the countries in which IGS is more common as compared to other countries, there may be a large number of unreported cases.</text><annotation id="14409"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21884" length="8" /><text>patients</text></annotation><annotation id="14410"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="21898" length="11" /><text>proteinuria</text></annotation><annotation id="14411"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22248" length="8" /><text>patients</text></annotation><annotation id="14412"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="22473" length="3" /><text>IGS</text></annotation><annotation id="14413"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="22548" length="11" /><text>proteinuria</text></annotation><annotation id="14414"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="22105" length="3" /><text>IGS</text></annotation><annotation id="14415"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="22393" length="3" /><text>IGS</text></annotation><annotation id="14416"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21738" length="8" /><text>patients</text></annotation><annotation id="14417"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="22412" length="11" /><text>proteinuria</text></annotation><annotation id="14418"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21832" length="8" /><text>patients</text></annotation><annotation id="14419"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="22053" length="3" /><text>IGS</text></annotation><annotation id="14420"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22513" length="8" /><text>patients</text></annotation><annotation id="14421"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="22180" length="3" /><text>IGS</text></annotation><annotation id="14422"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="22167" length="11" /><text>proteinuria</text></annotation><annotation id="14423"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22076" length="8" /><text>patients</text></annotation><annotation id="14424"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21920" length="8" /><text>patients</text></annotation><annotation id="14425"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="22605" length="3" /><text>IGS</text></annotation><annotation id="14426"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="21776" length="11" /><text>proteinuria</text></annotation><annotation id="14427"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="22342" length="11" /><text>proteinuria</text></annotation><annotation id="14428"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="22265" length="11" /><text>proteinuria</text></annotation><annotation id="14429"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21683" length="8" /><text>patients</text></annotation><annotation id="14430"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22018" length="8" /><text>patients</text></annotation><annotation id="14431"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="21846" length="11" /><text>proteinuria</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22705</offset><text>Tanner et al. previously hypothesized that proteinuria may only be observed in patients harboring AMN or CUBN variants that encode the cubilin-amnionless interaction domain, but not in patients with variants in CUBN in the IF-binding site. However, we also observed patients with AMN variants without proteinuria.</text><annotation id="14432"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="22810" length="4" /><text>CUBN</text></annotation><annotation id="14433"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="22840" length="7" /><text>cubilin</text></annotation><annotation id="14434"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="22916" length="4" /><text>CUBN</text></annotation><annotation id="14435"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="22985" length="3" /><text>AMN</text></annotation><annotation id="14436"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="22803" length="3" /><text>AMN</text></annotation><annotation id="14437"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="22848" length="10" /><text>amnionless</text></annotation><annotation id="14438"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="23006" length="11" /><text>proteinuria</text></annotation><annotation id="14439"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22890" length="8" /><text>patients</text></annotation><annotation id="14440"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22971" length="8" /><text>patients</text></annotation><annotation id="14441"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="22748" length="11" /><text>proteinuria</text></annotation><annotation id="14443"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22784" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23019</offset><text>Urinary tract abnormalities were observed in 10 patients (3.1% of IGS patients), of which 6 patients had genetic testing. In all cases, AMN variants were identified. CUBN variants were not identified in this specific cohort. Urinary tract abnormalities have indeed, been previously associated with AMN-related IGS, reflecting the role of AMN during embryonic development. The absence of CUBN variants in patients with urinary tract anomalies suggests a difference in the phenotypic spectrum with potential genotype-phenotype correlation. However, the numbers are too small to draw definitive conclusions. Also, congenital anomalies of the kidney and urinary tract are not rare. They represent approximately 20-30% of all anomalies identified in the prenatal period.</text><annotation id="14445"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="23155" length="3" /><text>AMN</text></annotation><annotation id="14446"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="23185" length="4" /><text>CUBN</text></annotation><annotation id="14447"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="23317" length="3" /><text>AMN</text></annotation><annotation id="14448"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="23406" length="4" /><text>CUBN</text></annotation><annotation id="14449"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="23357" length="3" /><text>AMN</text></annotation><annotation id="14450"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="23067" length="8" /><text>patients</text></annotation><annotation id="14451"><infon key="identifier">MESH:D014570</infon><infon key="type">Disease</infon><location offset="23437" length="23" /><text>urinary tract anomalies</text></annotation><annotation id="14452"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="23423" length="8" /><text>patients</text></annotation><annotation id="14453"><infon key="identifier">MESH:D014570</infon><infon key="type">Disease</infon><location offset="23019" length="27" /><text>Urinary tract abnormalities</text></annotation><annotation id="14454"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="23111" length="8" /><text>patients</text></annotation><annotation id="14455"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="23329" length="3" /><text>IGS</text></annotation><annotation id="14456"><infon key="identifier">MESH:D014570</infon><infon key="type">Disease</infon><location offset="23244" length="27" /><text>Urinary tract abnormalities</text></annotation><annotation id="14458"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="23085" length="3" /><text>IGS</text></annotation><annotation id="14459"><infon key="identifier">MESH:D007680</infon><infon key="type">Disease</infon><location offset="23630" length="38" /><text>congenital anomalies of the kidney and</text></annotation><annotation id="14460"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="23089" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>23787</offset><text>Diagnosis</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23797</offset><text>As described above, the observation of macrocytic anemia, vitB12 deficiency, and permanent proteinuria is highly suggestive of IGS. Because we observed that 92% of patients with IGS had proteinuria, we recommend health care providers to examine the urine in any child with a vitB12 deficiency.</text><annotation id="14461"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="23975" length="3" /><text>IGS</text></annotation><annotation id="14462"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="23855" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14463"><infon key="identifier">MESH:D000748</infon><infon key="type">Disease</infon><location offset="23836" length="17" /><text>macrocytic anemia</text></annotation><annotation id="14464"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="23961" length="8" /><text>patients</text></annotation><annotation id="14465"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="23888" length="11" /><text>proteinuria</text></annotation><annotation id="14466"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="23924" length="3" /><text>IGS</text></annotation><annotation id="14467"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="23983" length="11" /><text>proteinuria</text></annotation><annotation id="14468"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="24072" length="17" /><text>vitB12 deficiency</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24091</offset><text>Other clinical diagnostic findings may include thrombocytopenia, moderate leukopenia and neutropenia, and high levels of homocysteine and methylmalonic acid in serum or urine.</text><annotation id="14469"><infon key="identifier">MESH:D007970</infon><infon key="type">Disease</infon><location offset="24165" length="10" /><text>leukopenia</text></annotation><annotation id="14470"><infon key="identifier">MESH:D006710</infon><infon key="type">Chemical</infon><location offset="24212" length="12" /><text>homocysteine</text></annotation><annotation id="14471"><infon key="identifier">MESH:D013921</infon><infon key="type">Disease</infon><location offset="24138" length="16" /><text>thrombocytopenia</text></annotation><annotation id="14472"><infon key="identifier">MESH:D008764</infon><infon key="type">Chemical</infon><location offset="24229" length="18" /><text>methylmalonic acid</text></annotation><annotation id="14473"><infon key="identifier">MESH:D009503</infon><infon key="type">Disease</infon><location offset="24180" length="11" /><text>neutropenia</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24267</offset><text>IGS is diagnosed by detecting vitB12 deficiency and the molecular analysis of the CUBN and AMN genes to confirm IGS, and the CBLIF [Genbank NG_008120] gene to exclude IF-deficiency. If a molecular analysis is unavailable, serum vitB12, folate, methylmalonyl acid (accumulates in vitB12 deficiency but not in folate deficiency), homocysteine, and a myelogram (to rule out malignant conditions) may be helpful. Antibodies against IF can be investigated to exclude deficiency of IF as a cause of megaloblastic anemia. IF assays in the gastric fluid may be used to differentiate between IGS and IF deficiency.</text><annotation id="14474"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="24349" length="4" /><text>CUBN</text></annotation><annotation id="14475"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="24358" length="3" /><text>AMN</text></annotation><annotation id="14476"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="24267" length="3" /><text>IGS</text></annotation><annotation id="14477"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="24858" length="13" /><text>IF deficiency</text></annotation><annotation id="14478"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="24511" length="18" /><text>methylmalonyl acid</text></annotation><annotation id="14479"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="24850" length="3" /><text>IGS</text></annotation><annotation id="14480"><infon key="identifier">MESH:C562799</infon><infon key="type">Disease</infon><location offset="24575" length="17" /><text>folate deficiency</text></annotation><annotation id="14481"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="24379" length="3" /><text>IGS</text></annotation><annotation id="14482"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="24729" length="16" /><text>deficiency of IF</text></annotation><annotation id="14483"><infon key="identifier">MESH:D005492</infon><infon key="type">Chemical</infon><location offset="24503" length="6" /><text>folate</text></annotation><annotation id="14484"><infon key="identifier">MESH:D000749</infon><infon key="type">Disease</infon><location offset="24760" length="20" /><text>megaloblastic anemia</text></annotation><annotation id="14485"><infon key="identifier">MESH:D006710</infon><infon key="type">Chemical</infon><location offset="24595" length="12" /><text>homocysteine</text></annotation><annotation id="14486"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="24434" length="13" /><text>IF-deficiency</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24873</offset><text>In addition, a test to demonstrate that vitB12 is poorly absorbed, such as the Schilling test, a radiolabeled vitB12 absorption test to confirm vitB12 malabsorption [, has been used. However, this test does not distinguish between IGS and congenital IF deficiency (absence or production of inert IF). In the two-stage Schilling test, IF was added to one of the steps, which resulted in the correction of IF deficiency, but not of IGS. Another limitation of the Schilling test is that vitB12 deficiency may affect the enterocyte function, leading to secondary malabsorption and an abnormal Schilling test. Currently, the Schilling test is not available in most countries due to the difficulty to obtain labeled cobalamine. Other tests using, for example cyano-vitB12 to measure the fraction of transcobalamin bound to cyano-vitB12, are proposed by previous authors, who however, also expressed concerns about its sensitivity. No replacement test has been validated. A therapeutic test with vitB12 or folate can be useful.</text><annotation id="14487"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="25104" length="3" /><text>IGS</text></annotation><annotation id="14488"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25583" length="10" /><text>cobalamine</text></annotation><annotation id="14489"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="24913" length="6" /><text>vitB12</text></annotation><annotation id="14490"><infon key="identifier">MESH:D008286</infon><infon key="type">Disease</infon><location offset="25432" length="13" /><text>malabsorption</text></annotation><annotation id="14491"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25017" length="20" /><text>vitB12 malabsorption</text></annotation><annotation id="14492"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="24983" length="6" /><text>vitB12</text></annotation><annotation id="14493"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="25277" length="13" /><text>IF deficiency</text></annotation><annotation id="14494"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="25112" length="24" /><text>congenital IF deficiency</text></annotation><annotation id="14495"><infon key="identifier">MESH:D005492</infon><infon key="type">Chemical</infon><location offset="25872" length="6" /><text>folate</text></annotation><annotation id="14496"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25690" length="12" /><text>cyano-vitB12</text></annotation><annotation id="14497"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="25303" length="3" /><text>IGS</text></annotation><annotation id="14498"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25626" length="12" /><text>cyano-vitB12</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>25894</offset><text>Mutations</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25904</offset><text>In 1999, CUBN mutations were first described in a group of Finnish patients with vitB12 deficiency and proteinuria, followed by AMN mutations observed in Norwegian and Jewish patients. Because CUBN and AMN were not recognized until after 1999 as the genes responsible for IGS, many of the previously published cases of IGS were found not to be due to IGS but rather to defects in IF. Tanner et al. carried out genetic screening in 154 cases of suspected inherited vitB12 malabsorption. Of these patients, 64% of patients had either a CUBN or AMN mutation, 18% of patients had a CBLIF mutation, and 18% had no mutation that could be identified. The authors suggested several other candidate genes based on their role in vitB12 transport, but none of these mutations could be confirmed in their patients.</text><annotation id="14499"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="25913" length="4" /><text>CUBN</text></annotation><annotation id="14500"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="26446" length="3" /><text>AMN</text></annotation><annotation id="14501"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="26106" length="3" /><text>AMN</text></annotation><annotation id="14502"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="26032" length="3" /><text>AMN</text></annotation><annotation id="14503"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="26438" length="4" /><text>CUBN</text></annotation><annotation id="14504"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="26097" length="4" /><text>CUBN</text></annotation><annotation id="14505"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="26255" length="3" /><text>IGS</text></annotation><annotation id="14506"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="26176" length="3" /><text>IGS</text></annotation><annotation id="14507"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="26284" length="2" /><text>IF</text></annotation><annotation id="14509"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="25985" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14510"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26697" length="8" /><text>patients</text></annotation><annotation id="14511"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26399" length="8" /><text>patients</text></annotation><annotation id="14513"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="26223" length="3" /><text>IGS</text></annotation><annotation id="14515"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="25971" length="8" /><text>patients</text></annotation><annotation id="14517"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="26368" length="20" /><text>vitB12 malabsorption</text></annotation><annotation id="14518"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="26007" length="11" /><text>proteinuria</text></annotation><annotation id="14520"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26467" length="8" /><text>patients</text></annotation><annotation id="14521"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26079" length="8" /><text>patients</text></annotation><annotation id="14522"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26416" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26707</offset><text>We found 119 different mutations in either CUBN or AMN genes. In 48% of cases that have been classified as IGS, genetic testing has not been performed. In 24% of these patients, other diagnostic tests were carried out suggesting IGS, including in 22% a Schilling test and in 2% a test to rule out an IF deficiency.</text><annotation id="14523"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="26750" length="4" /><text>CUBN</text></annotation><annotation id="14524"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="26758" length="3" /><text>AMN</text></annotation><annotation id="14525"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26875" length="8" /><text>patients</text></annotation><annotation id="14526"><infon key="identifier">MESH:C563242</infon><infon key="type">Disease</infon><location offset="27007" length="13" /><text>IF deficiency</text></annotation><annotation id="14527"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="26936" length="3" /><text>IGS</text></annotation><annotation id="14528"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="26814" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27022</offset><text>Most of the patients have proteinuria, and therefore probably IGS. But some of the patients may have another cause of vitB12 deficiency, as suggested by Tanner et al.. However, due to the limitations described in the previous section, these cases should be (if possible) reassessed using molecular analysis to either confirm or reject the diagnosis of IGS.</text><annotation id="14529"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27374" length="3" /><text>IGS</text></annotation><annotation id="14530"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27084" length="3" /><text>IGS</text></annotation><annotation id="14531"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27105" length="8" /><text>patients</text></annotation><annotation id="14532"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="27048" length="11" /><text>proteinuria</text></annotation><annotation id="14533"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27034" length="8" /><text>patients</text></annotation><annotation id="14534"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="27140" length="17" /><text>vitB12 deficiency</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>27379</offset><text>Comorbidity</text><annotation id="14535"><infon key="identifier">MESH:D004194</infon><infon key="type">Disease</infon><location offset="27379" length="11" /><text>Comorbidity</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27391</offset><text>In 15% of IGS patients, other diseases in addition to IGS were present, such as congenital adrenal hyperplasia in patient 2. As previously mentioned, patients with IGS probably have a high rate of comorbidity due to the high rate of consanguinity. Urinary tract abnormalities are observed relatively frequently, the pathophysiology of which is described in more detail earlier in this report.</text><annotation id="14536"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27541" length="8" /><text>patients</text></annotation><annotation id="14537"><infon key="identifier">MESH:D014570</infon><infon key="type">Disease</infon><location offset="27639" length="27" /><text>Urinary tract abnormalities</text></annotation><annotation id="14538"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27505" length="7" /><text>patient</text></annotation><annotation id="14539"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27445" length="3" /><text>IGS</text></annotation><annotation id="14540"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27555" length="3" /><text>IGS</text></annotation><annotation id="14541"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27405" length="8" /><text>patients</text></annotation><annotation id="14542"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27401" length="3" /><text>IGS</text></annotation><annotation id="14543"><infon key="identifier">MESH:D000312</infon><infon key="type">Disease</infon><location offset="27471" length="30" /><text>congenital adrenal hyperplasia</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>27784</offset><text>Treatment</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27794</offset><text>Initially, vitB12 deficiency in IGS patients was corrected with monthly intramuscular injections of vitB12. One would expect a lack of effect of oral vitB12 since IGS is caused by malabsorption of vitB12 2. However, as with our patient, effective oral treatment with vitB12 has been previously described. Oral treatment is based on the assumption that if the dose is high enough, a small but still sufficient part is absorbed. Because approximately 1% of oral vitB12 is absorbed by passive diffusion in its free form, high doses can effectively treat vitB12 deficiency, also in patients with IGS. VitB12 needs to be administered throughout life in IGS.</text><annotation id="14544"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="27974" length="25" /><text>malabsorption of vitB12 2</text></annotation><annotation id="14545"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="28254" length="6" /><text>vitB12</text></annotation><annotation id="14546"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="28345" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14547"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="28442" length="3" /><text>IGS</text></annotation><annotation id="14548"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="28022" length="7" /><text>patient</text></annotation><annotation id="14549"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27830" length="8" /><text>patients</text></annotation><annotation id="14550"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27957" length="3" /><text>IGS</text></annotation><annotation id="14551"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="28061" length="6" /><text>vitB12</text></annotation><annotation id="14552"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="28372" length="8" /><text>patients</text></annotation><annotation id="14553"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="28386" length="3" /><text>IGS</text></annotation><annotation id="14554"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="27826" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>28447</offset><text>Prognosis</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28457</offset><text>IGS patients treated with vitB12 are clinically and hematologically normal. The proteinuria persists but does not increase in severity The kidney function does not deteriorate. However, to the authors' knowledge, the long-term studies only described patients up to the age of 46 years.</text><annotation id="14555"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="28537" length="11" /><text>proteinuria</text></annotation><annotation id="14556"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="28461" length="8" /><text>patients</text></annotation><annotation id="14557"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="28707" length="8" /><text>patients</text></annotation><annotation id="14558"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="28457" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_2</infon><offset>28745</offset><text>Limitations</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28757</offset><text>Firstly, the clinical details of the IGS patients described above are limited. Secondly, due to the lack of genetic testing in 48% of the patients included in this study, the diagnosis of IGS cannot be completely certain. Thirdly, particularly in relatively high-prevalence countries such as Norway and Finland, many cases may not have been reported. Finally, IGS may be grossly under-diagnosed as most patients present with non-specific symptoms. While a combination of vitB12 deficiency and proteinuria leads to additional diagnostic tests to diagnose IGS, in the absence of proteinuria, IGS may not be recognized. We also observed a high rate of oral mucosal lesions and neurological symptoms such as ataxia, all of which can lead to further diagnostic testing. Therefore, we expect that IGS will be significantly underdiagnosed and that we observed an overestimation of some clinical manifestations.</text><annotation id="14559"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29311" length="3" /><text>IGS</text></annotation><annotation id="14560"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="28895" length="8" /><text>patients</text></annotation><annotation id="14561"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29347" length="3" /><text>IGS</text></annotation><annotation id="14562"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29117" length="3" /><text>IGS</text></annotation><annotation id="14563"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="28798" length="8" /><text>patients</text></annotation><annotation id="14564"><infon key="identifier">MESH:D009059</infon><infon key="type">Disease</infon><location offset="29406" length="20" /><text>oral mucosal lesions</text></annotation><annotation id="14565"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="29334" length="11" /><text>proteinuria</text></annotation><annotation id="14566"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="29250" length="11" /><text>proteinuria</text></annotation><annotation id="14567"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="28794" length="3" /><text>IGS</text></annotation><annotation id="14568"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29160" length="8" /><text>patients</text></annotation><annotation id="14569"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="28945" length="3" /><text>IGS</text></annotation><annotation id="14570"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="29431" length="21" /><text>neurological symptoms</text></annotation><annotation id="14571"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29548" length="3" /><text>IGS</text></annotation><annotation id="14572"><infon key="identifier">MESH:D001259</infon><infon key="type">Disease</infon><location offset="29461" length="6" /><text>ataxia</text></annotation></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>29661</offset><text>Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>29673</offset><text>IGS is a rare autosomal recessive disorder characterized by vitB12 deficiency and in most patients, proteinuria. We reviewed the literature on IGS and, for the first time, all previously published cases of IGS. In addition, we describe two new patients. Most patients present with non-specific symptoms. If untreated, patients may develop severe (neurological) manifestations. Patients may be treated with oral vitB12 supplementations but may need higher doses. Because 92% of patients with IGS had proteinuria, we advise health-care providers to examine the urine of any child with vitB12 deficiency.</text><annotation id="14573"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="29687" length="28" /><text>autosomal recessive disorder</text></annotation><annotation id="14574"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="30172" length="11" /><text>proteinuria</text></annotation><annotation id="14575"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29879" length="3" /><text>IGS</text></annotation><annotation id="14576"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29673" length="3" /><text>IGS</text></annotation><annotation id="14577"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29932" length="8" /><text>patients</text></annotation><annotation id="14578"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="29733" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14579"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="30050" length="8" /><text>Patients</text></annotation><annotation id="14580"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29991" length="8" /><text>patients</text></annotation><annotation id="14581"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29763" length="8" /><text>patients</text></annotation><annotation id="14582"><infon key="identifier">MESH:D011507</infon><infon key="type">Disease</infon><location offset="29773" length="11" /><text>proteinuria</text></annotation><annotation id="14583"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="30164" length="3" /><text>IGS</text></annotation><annotation id="14584"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29917" length="8" /><text>patients</text></annotation><annotation id="14585"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="30084" length="6" /><text>vitB12</text></annotation><annotation id="14586"><infon key="identifier">MESH:D014806</infon><infon key="type">Disease</infon><location offset="30256" length="17" /><text>vitB12 deficiency</text></annotation><annotation id="14587"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="29816" length="3" /><text>IGS</text></annotation><annotation id="14588"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="30150" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_2</infon><offset>30275</offset><text>Electronic supplementary material</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>30309</offset><text>Below is the link to the electronic supplementary material.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">footnote</infon><offset>30369</offset><text>Publisher's Note</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">footnote</infon><offset>30388</offset><text>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>30507</offset><text>Authors' contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>30532</offset><text>SDKK: Conception and design, data acquisition, analysis and interpretation, manuscript draft and revision. JN: Data acquisition, analysis, and interpretation, manuscript revision. AB: Manuscript draft and revision. MECM: Manuscript draft and revision. MvdA: Conception and design, manuscript draft and revision.</text><annotation id="14589"><infon key="type">Disease</infon><location offset="30747" length="4" /><text>MECM</text></annotation></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title</infon><offset>30844</offset><text>Funding</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>30852</offset><text>Not applicable.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>30868</offset><text>Data availability</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>30886</offset><text>All data generated or analyzed during this study are included in this published article [and its supplementary information files].</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>31017</offset><text>Declarations</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31030</offset><text>Not applicable.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>31046</offset><text>Ethics approval and consent to participate</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31089</offset><text>Not applicable.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>31105</offset><text>Consent for publication</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31129</offset><text>Informed consent was obtained from the index patients included in the study.</text><annotation id="14590"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="31174" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>31206</offset><text>Competing interests</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>31226</offset><text>Not applicable.</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title</infon><offset>31242</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31256</offset><text>AMN</text><annotation id="14591"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="31256" length="3" /><text>AMN</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31260</offset><text>Amnionless/amnion-associated transmembrane protein</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31311</offset><text>CBLIF</text><annotation id="14593"><infon key="type">Disease</infon><location offset="31311" length="5" /><text>CBLIF</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31317</offset><text>Cobalamin binding intrinsic factor</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31352</offset><text>CUBN</text><annotation id="14594"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="31352" length="4" /><text>CUBN</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31357</offset><text>Cubilin</text><annotation id="14596"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="31357" length="7" /><text>Cubilin</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31365</offset><text>CYP21A2</text><annotation id="14597"><infon key="identifier">1589</infon><infon key="type">Gene</infon><location offset="31365" length="7" /><text>CYP21A2</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31373</offset><text>cytochrome P450 family 21 subfamily A member 2</text><annotation id="14598"><infon key="identifier">1589</infon><infon key="type">Gene</infon><location offset="31373" length="46" /><text>cytochrome P450 family 21 subfamily A member 2</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31420</offset><text>ER</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31423</offset><text>Endoplasmatic reticulum</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31447</offset><text>IF</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31450</offset><text>Intrinsic factor</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31467</offset><text>IGS</text><annotation id="14599"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="31467" length="3" /><text>IGS</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31471</offset><text>Imerslund-Grasbeck syndrome</text><annotation id="14600"><infon key="identifier">MESH:C538556</infon><infon key="type">Disease</infon><location offset="31471" length="27" /><text>Imerslund-Grasbeck syndrome</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31499</offset><text>LDH</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31503</offset><text>Lactate dehydrogenase</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31525</offset><text>VitB12</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>31532</offset><text>Vitamin B12</text><annotation id="14601"><infon key="identifier">MESH:D014805</infon><infon key="type">Chemical</infon><location offset="31532" length="11" /><text>Vitamin B12</text></annotation></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>31544</offset><text>References</text></passage><passage><infon key="volume">1</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Grasbeck;given-names:R</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="year">2006</infon><infon key="source">Orphanet J Rare Dis</infon><infon key="type">ref</infon><infon key="lpage">6</infon><offset>31555</offset><text>Imerslund-Grasbeck syndrome (selective vitamin B12 malabsorption with proteinuria)</text></passage><passage><infon key="volume">49</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Imerslund;given-names:O</infon><infon key="fpage">208</infon><infon key="issue">Suppl</infon><infon key="year">1960</infon><infon key="source">Acta Paediatr</infon><infon key="type">ref</infon><infon key="lpage">9</infon><offset>31639</offset><text>Idiopathic chronic megaloblastic anemia in children</text></passage><passage><infon key="name_3">surname:Kuhlback;given-names:B</infon><infon key="volume">167</infon><infon key="name_2">surname:Kantero;given-names:I</infon><infon key="name_1">surname:Gordin;given-names:R</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Grasbeck;given-names:R</infon><infon key="fpage">289</infon><infon key="pub-id_pmid">13828999</infon><infon key="year">1960</infon><infon key="source">Acta Med Scand</infon><infon key="type">ref</infon><infon key="lpage">96</infon><offset>31691</offset><text>Selective vitamin B12 malabsorption and proteinuria in young people. A syndrome</text></passage><passage><infon key="volume">33</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Stieglitz;given-names:EJ</infon><infon key="fpage">58</infon><infon key="issue">1</infon><infon key="year">1924</infon><infon key="source">Arch Intern Med</infon><infon key="type">ref</infon><infon key="lpage">70</infon><offset>31771</offset><text>Disturbances of renal function in pernicious Anemia</text></passage><passage><infon key="name_3">surname:Liyanarachchi;given-names:S</infon><infon key="name_2">surname:Baack;given-names:EC</infon><infon key="name_1">surname:Sturm;given-names:AC</infon><infon key="name_0">surname:Tanner;given-names:SM</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="pub-id_pmid">22214468</infon><infon key="year">2012</infon><infon key="source">Orphanet J Rare Dis</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="section_type">REF</infon><infon key="lpage">15</infon><infon key="name_4">surname:De La Chapelle;given-names:A</infon><offset>31823</offset><text>Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns</text></passage><passage><infon key="volume">38</infon><infon key="name_2">surname:Nebe;given-names:CT</infon><infon key="name_1">surname:Heimpel;given-names:H</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Gutgemann;given-names:I</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="year">2014</infon><infon key="source">LaboratoriumsMedizin</infon><infon key="type">ref</infon><infon key="lpage">5</infon><offset>31921</offset><text>Significance of teardrop cells in peripheral blood smears</text></passage><passage><infon key="volume">125</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Sievers;given-names:CJ</infon><infon key="fpage">1744</infon><infon key="pub-id_pmid">14103839</infon><infon key="year">1963</infon><infon key="source">Ugeskr Laeg</infon><infon key="type">ref</infon><infon key="lpage">7</infon><offset>31979</offset><text>Megaloblastaer anaemi hos ett nicieuse de I'enfant avec activitt 'facteur in- 3-lrs barn</text></passage><passage><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Eslamiyeh;given-names:H</infon><infon key="fpage">105</infon><infon key="issue">4</infon><infon key="pub-id_pmid">34782847</infon><infon key="year">2021</infon><infon key="source">Iran J Child Neurol</infon><infon key="type">ref</infon><infon key="lpage">8</infon><offset>32072</offset><text>Acute cerebellar ataxia as the first manifestation of Imerslund-Grasbeck</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>32146</offset><text>Li J, Gao MH, Gao XJ, Lau K. A child with megaloblastic anemia and proteinuria: answers. Pediatr Nephrol. 2022;(0123456789):10-2.</text></passage><passage><infon key="name_3">surname:Zhou;given-names:L</infon><infon key="name_2">surname:Deng;given-names:L</infon><infon key="name_1">surname:Xu;given-names:Y</infon><infon key="name_0">surname:Yang;given-names:J</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="pub-id_pmid">34979951</infon><infon key="year">2022</infon><infon key="source">BMC Nephrol</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="section_type">REF</infon><infon key="lpage">8</infon><infon key="name_5">surname:Zhang;given-names:Y</infon><infon key="name_4">surname:Qiu;given-names:L</infon><offset>32278</offset><text>CUBN gene mutations may cause focal segmental glomerulosclerosis (FSGS) in children</text><annotation id="14602"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="32278" length="4" /><text>CUBN</text></annotation></passage><passage><infon key="name_3">surname:Shaw;given-names:GR</infon><infon key="name_2">surname:Salsbery;given-names:KT</infon><infon key="name_1">surname:Parikh;given-names:NS</infon><infon key="name_0">surname:Baker;given-names:KM</infon><infon key="fpage">1</infon><infon key="issue">00</infon><infon key="year">2021</infon><infon key="source">J Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">00</infon><infon key="section_type">REF</infon><infon key="lpage">3</infon><infon key="name_5">surname:Oelstrom;given-names:MJ</infon><infon key="name_4">surname:Steiner;given-names:RD</infon><offset>32362</offset><text>A 17-Month-old boy with Pancytopenia caused by a rare genetic defect of vitamin B12 malabsorption</text></passage><passage><infon key="name_3">surname:Oner;given-names:C</infon><infon key="name_2">surname:Perko;given-names:JD</infon><infon key="name_1">surname:Li;given-names:Z</infon><infon key="name_0">surname:Tanner;given-names:SM</infon><infon key="fpage">4130</infon><infon key="issue">11</infon><infon key="pub-id_pmid">15738392</infon><infon key="year">2005</infon><infon key="source">Proc Natl Acad Sci U S A</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="section_type">REF</infon><infon key="lpage">3</infon><infon key="name_5">surname:Altay;given-names:C</infon><infon key="name_4">surname:Cetin;given-names:M</infon><offset>32460</offset><text>Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene</text></passage><passage><infon key="volume">271</infon><infon key="name_2">surname:Jiji;given-names:RM</infon><infon key="name_1">surname:Sacks;given-names:MS</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Spurling;given-names:CL</infon><infon key="fpage">995</infon><infon key="pub-id_pmid">14198065</infon><infon key="year">1964</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="lpage">1003</infon><offset>32550</offset><text>Juvenile pernicious Anemia</text></passage><passage><infon key="name_3">surname:Grenet;given-names:P</infon><infon key="name_2">surname:Ravailleau;given-names:J</infon><infon key="name_1">surname:Najean;given-names:Y</infon><infon key="name_0">surname:Chavelet;given-names:F</infon><infon key="fpage">311</infon><infon key="pub-id_pmid">14148291</infon><infon key="year">1964</infon><infon key="source">Nouv Rev Fr Hematol</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_4">surname:Bernard;given-names:J</infon><offset>32577</offset><text>Study of a case of pernicious anemia in a child with normal intrinsic factor activity in its gastric juice</text></passage><passage><infon key="volume">35</infon><infon key="name_2">surname:Galloway;given-names:WH</infon><infon key="name_1">surname:McKay;given-names:E</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Mohamed;given-names:SD</infon><infon key="fpage">433</infon><infon key="issue">139</infon><infon key="pub-id_pmid">5956445</infon><infon key="year">1966</infon><infon key="source">Q J Med</infon><infon key="type">ref</infon><infon key="lpage">53</infon><offset>32684</offset><text>Juvenile familial megaloblastic anaemia due to selective malabsorption of vitamin B-12. A family study and a review of the literature</text></passage><passage><infon key="volume">55</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Hippe;given-names:E</infon><infon key="fpage">510</infon><infon key="issue">5</infon><infon key="pub-id_pmid">5970753</infon><infon key="year">1966</infon><infon key="source">Acta Paediatr Scand</infon><infon key="type">ref</infon><infon key="lpage">6</infon><offset>32818</offset><text>Malabsorption of vitamin B12. Report of a case in a 1-year-old boy, including studies of the absorption of B12</text></passage><passage><infon key="name_3">surname:Chapuis;given-names:G</infon><infon key="name_2">surname:Pacrean;given-names:B</infon><infon key="name_1">surname:Najean;given-names:Y</infon><infon key="name_0">surname:Castel;given-names:Y</infon><infon key="fpage">573</infon><infon key="year">1966</infon><infon key="source">Ouest mtd</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="section_type">REF</infon><infon key="lpage">90</infon><infon key="name_5">surname:Mollaret;given-names:J</infon><infon key="name_4">surname:Saleun;given-names:G</infon><offset>32929</offset><text>La malabsorption specifique de la vitamine B 12 avec proteinurie: Anemie pernicieuse d'imerslund-Najman-Grasbeck. Trois observations dans la meme fratrie</text></passage><passage><infon key="volume">177</infon><infon key="name_1">surname:Salmi;given-names:HA</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Anttila;given-names:R</infon><infon key="fpage">90</infon><infon key="year">1967</infon><infon key="source">Acta Paediatr Scand</infon><infon key="type">ref</infon><infon key="lpage">1</infon><offset>33085</offset><text>Selective malabsorption of vitamin B12 with proteinuria in children</text></passage><passage><infon key="name_3">surname:Weissenbach;given-names:J</infon><infon key="name_2">surname:Grasbeck;given-names:R</infon><infon key="name_1">surname:Tahvanainen;given-names:E</infon><infon key="name_0">surname:Aminoff;given-names:M</infon><infon key="fpage">824</infon><infon key="issue">4</infon><infon key="pub-id_pmid">7573042</infon><infon key="year">1995</infon><infon key="source">Am J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="section_type">REF</infon><infon key="lpage">31</infon><infon key="name_5">surname:De la Chapelle;given-names:A</infon><infon key="name_4">surname:Broch;given-names:H</infon><offset>33153</offset><text>Selective intestinal malabsorption of vitamin B12 displays recessive mendelian inheritance: assignment of a locus to chromosome 10 by linkage</text></passage><passage><infon key="volume">52</infon><infon key="name_2">surname:Rubin;given-names:CE</infon><infon key="name_1">surname:Brandborg;given-names:LL</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Lillibridge;given-names:CB</infon><infon key="fpage">792</infon><infon key="issue">5</infon><infon key="pub-id_pmid">5337292</infon><infon key="year">1967</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="lpage">809</infon><offset>33295</offset><text>Childhood pernicious Anemia: gastrointestinal secretory, histological, and electron microscopic aspects</text></passage><passage><infon key="volume">14</infon><infon key="name_2">surname:Guillien;given-names:F</infon><infon key="name_1">surname:Salama;given-names:C</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Gorin;given-names:R</infon><infon key="fpage">1383</infon><infon key="issue">5</infon><infon key="pub-id_pmid">4898275</infon><infon key="year">1967</infon><infon key="source">Ann Pediatr (Paris)</infon><infon key="type">ref</infon><infon key="lpage">97</infon><offset>33399</offset><text>Apropos of a new case of anemia due to specific malaborsorption of vitamin B12 with proteinuria: study of the megaloblastic anemias of infants due to primary B12 avitaminosis</text></passage><passage><infon key="name_3">surname:Fischbach;given-names:H</infon><infon key="volume">124</infon><infon key="name_2">surname:Weber;given-names:H-P</infon><infon key="name_1">surname:Rotthauwe;given-names:HW</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Becker;given-names:M</infon><infon key="fpage">139</infon><infon key="year">1977</infon><infon key="source">Eur J Med Genet</infon><infon key="type">ref</infon><infon key="lpage">53</infon><offset>33574</offset><text>Selective vitamin Bl2 malabsorption (Imerslund-Graisbeck syndrome) studies on gastroenterological and nephrological problems</text></passage><passage><infon key="name_3">surname:Hoffbrand;given-names:A</infon><infon key="volume">2</infon><infon key="name_2">surname:Rossiter;given-names:M</infon><infon key="name_1">surname:Marsh;given-names:G</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Attock;given-names:B</infon><infon key="fpage">807</infon><infon key="issue">6090</infon><infon key="pub-id_pmid">912333</infon><infon key="year">1977</infon><infon key="source">Br Med J</infon><infon key="type">ref</infon><offset>33699</offset><text>Selective malabsorption of vitamin B12without proteinuria or structural renal tract anomaly</text></passage><passage><infon key="volume">15</infon><infon key="name_2">surname:Marsden;given-names:DE</infon><infon key="name_1">surname:Newman;given-names:NM</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Marsden;given-names:KA</infon><infon key="fpage">49</infon><infon key="issue">1</infon><infon key="year">1979</infon><infon key="source">J Paediatr Child Health</infon><infon key="type">ref</infon><infon key="lpage">52</infon><offset>33791</offset><text>Imerslund's Syndrome A Case from Australia and Review of the literature</text></passage><passage><infon key="volume">23</infon><infon key="name_2">surname:Jokinen;given-names:EJ</infon><infon key="name_1">surname:Lahdevirta;given-names:J</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Collan;given-names:Y</infon><infon key="fpage">297</infon><infon key="issue">6</infon><infon key="pub-id_pmid">384282</infon><infon key="year">1979</infon><infon key="source">Nephron</infon><infon key="type">ref</infon><infon key="lpage">303</infon><offset>33865</offset><text>Selective vitamin B12 malabsorption with Proteinuria</text></passage><passage><infon key="volume">57</infon><infon key="name_2">surname:Paynter;given-names:AS</infon><infon key="name_1">surname:Inglis;given-names:J</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Campbell;given-names:AN</infon><infon key="fpage">509</infon><infon key="issue">670</infon><infon key="pub-id_pmid">7301700</infon><infon key="year">1981</infon><infon key="source">Postgrad Med J</infon><infon key="type">ref</infon><infon key="lpage">10</infon><offset>33918</offset><text>Failure to thrive associated with the Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Hovig;given-names:T</infon><infon key="volume">73</infon><infon key="name_2">surname:Monn;given-names:E</infon><infon key="name_1">surname:Imerslund;given-names:O</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Broch;given-names:H</infon><infon key="fpage">248</infon><infon key="year">1984</infon><infon key="source">Acta Paediatr</infon><infon key="type">ref</infon><infon key="lpage">53</infon><infon key="name_4">surname:Seip;given-names:M</infon><offset>33984</offset><text>Imerslund-Grasbeck Anemia. A long-term follow-up study</text></passage><passage><infon key="name_3">surname:Phillips;given-names:AD</infon><infon key="name_2">surname:Walker-Smith;given-names:JA</infon><infon key="name_1">surname:Jenkins;given-names:WJ</infon><infon key="name_0">surname:Burman;given-names:JF</infon><infon key="fpage">311</infon><infon key="issue">3</infon><infon key="pub-id_pmid">3972280</infon><infon key="year">1985</infon><infon key="source">Gut</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="section_type">REF</infon><infon key="lpage">4</infon><infon key="name_5">surname:Williams;given-names:CB</infon><infon key="name_4">surname:Sourial;given-names:NA</infon><offset>34039</offset><text>Absent ileal uptake of IF-bound vitamin B12 in vivo in the Imerslund-Grasbeck syndrome (familial vitamin B12 malabsorption with proteinuria)</text></passage><passage><infon key="volume">74</infon><infon key="name_2">surname:Campbell;given-names:A</infon><infon key="name_1">surname:Thom;given-names:H</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Auchterlonie;given-names:I</infon><infon key="fpage">469</infon><infon key="issue">3</infon><infon key="year">1985</infon><infon key="source">Acta Paediatrica</infon><infon key="type">ref</infon><infon key="lpage">71</infon><offset>34180</offset><text>Selective vitamin B12 malabsorption without anaemia but with profound failure to Thrive</text></passage><passage><infon key="volume">77</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chisholm;given-names:JC</infon><infon key="fpage">835</infon><infon key="issue">10</infon><infon key="pub-id_pmid">4057272</infon><infon key="year">1985</infon><infon key="source">J Natl Med Assoc</infon><infon key="type">ref</infon><infon key="lpage">8</infon><offset>34268</offset><text>Selective malabsorption of vitamin B12 and vitamin B12- intrinsic factor with megaloblastic anemia in an adult</text></passage><passage><infon key="volume">81</infon><infon key="name_2">surname:Oseas;given-names:R</infon><infon key="name_1">surname:Hyman;given-names:P</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Russo;given-names:C</infon><infon key="fpage">875</infon><infon key="issue">6</infon><infon key="pub-id_pmid">3368285</infon><infon key="year">1988</infon><infon key="source">Pediatrics</infon><infon key="type">ref</infon><infon key="lpage">6</infon><offset>34379</offset><text>Megaloblastic Anemia characterized by microcytosis: Imerslund-Grasbeck Syndrome with Coexistent a-thalassemia</text></passage><passage><infon key="name_3">surname:Doyle;given-names:EF</infon><infon key="name_2">surname:McKay;given-names:RJJ</infon><infon key="name_1">surname:Wolff;given-names:JA</infon><infon key="name_0">surname:Reisner;given-names:EHJ</infon><infon key="fpage">88</infon><infon key="issue">1</infon><infon key="pub-id_pmid">14853623</infon><infon key="year">1951</infon><infon key="source">Pediatrics</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="section_type">REF</infon><infon key="lpage">106</infon><offset>34489</offset><text>Juvenile pernicious anemia</text></passage><passage><infon key="volume">73</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Smith;given-names:C</infon><infon key="fpage">607</infon><infon key="pub-id_pmid">3375911</infon><infon key="year">1988</infon><infon key="source">SAMJ</infon><infon key="type">ref</infon><offset>34516</offset><text>Selective cobalamin (vitamin B 12) malabsorption in adolescence</text></passage><passage><infon key="name_3">surname:Banerjee;given-names:G</infon><infon key="volume">3</infon><infon key="name_2">surname:Aggarwal;given-names:V</infon><infon key="name_1">surname:Sudarshan;given-names:G</infon><infon key="section_type">REF</infon><infon key="name_0">surname:el Mauhoub;given-names:M</infon><infon key="fpage">180</infon><infon key="year">1989</infon><infon key="source">Ann Trop Paediatr</infon><infon key="type">ref</infon><infon key="lpage">1</infon><offset>34580</offset><text>Imerslund-Grasbeck syndrome in a lybian boy</text></passage><passage><infon key="volume">7</infon><infon key="name_2">surname:Koren;given-names:A</infon><infon key="name_1">surname:Katzuni;given-names:E</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ben-Ami;given-names:M</infon><infon key="fpage">177</infon><infon key="issue">2</infon><infon key="pub-id_pmid">2169845</infon><infon key="year">1990</infon><infon key="source">Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="lpage">81</infon><offset>34624</offset><text>Imerslund syndrome with dolichocephaly</text></passage><passage><infon key="volume">80</infon><infon key="name_1">surname:Ahmed;given-names:AF</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Abdelaal;given-names:MA</infon><infon key="fpage">1109</infon><infon key="issue">11</infon><infon key="pub-id_pmid">1750351</infon><infon key="year">1991</infon><infon key="source">Acta Paediatr Scand</infon><infon key="type">ref</infon><infon key="lpage">12</infon><offset>34663</offset><text>Imerslund-Grasbeck syndrome in a saudi family</text></passage><passage><infon key="volume">238</infon><infon key="name_2">surname:Mohdi;given-names:AA</infon><infon key="name_1">surname:Banda;given-names:RW</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Salameh;given-names:MM</infon><infon key="fpage">349</infon><infon key="issue">6</infon><infon key="pub-id_pmid">1940989</infon><infon key="year">1991</infon><infon key="source">J Neurol</infon><infon key="type">ref</infon><infon key="lpage">50</infon><offset>34709</offset><text>Reversal of severe neurological abnormalities after vitamin B12 replacement in the Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Wei;given-names:KN</infon><infon key="name_2">surname:Huang;given-names:FY</infon><infon key="name_1">surname:Hsu;given-names:HC</infon><infon key="name_0">surname:Liang;given-names:DC</infon><infon key="fpage">361</infon><infon key="issue">4</infon><infon key="pub-id_pmid">1782115</infon><infon key="year">1991</infon><infon key="source">Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><offset>34820</offset><text>Imerslund-grasbeck syndrome in two brothers: renal biopsy and ultrastructural findings</text></passage><passage><infon key="name_3">surname:Hsueh;given-names:EJ</infon><infon key="name_2">surname:Lu;given-names:KC</infon><infon key="name_1">surname:Sourial;given-names:NA</infon><infon key="name_0">surname:Lin;given-names:SH</infon><infon key="fpage">956</infon><infon key="issue">10</infon><infon key="pub-id_pmid">7962612</infon><infon key="year">1994</infon><infon key="source">J Clin Pathol</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="section_type">REF</infon><infon key="lpage">8</infon><offset>34908</offset><text>Imerslund-Grasbeck syndrome in a chinese family with distinct skin lesions refractory to vitamin B12</text></passage><passage><infon key="name_3">surname:Irken;given-names:G</infon><infon key="name_2">surname:Gumruk;given-names:F</infon><infon key="name_1">surname:Cetin;given-names:M</infon><infon key="name_0">surname:Altay;given-names:C</infon><infon key="fpage">19</infon><infon key="issue">1</infon><infon key="pub-id_pmid">7703038</infon><infon key="year">1995</infon><infon key="source">Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="section_type">REF</infon><infon key="lpage">28</infon><infon key="name_5">surname:Laleli;given-names:Y</infon><infon key="name_4">surname:Yetgin;given-names:S</infon><offset>35009</offset><text>Familial selective vitamin b12 malabsorption (imerslund-grasbeck syndrome) in a pool of turkish patients</text></passage><passage><infon key="volume">13</infon><infon key="name_2">surname:Schiliro;given-names:G</infon><infon key="name_1">surname:Romano;given-names:V</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Gangarossa;given-names:S</infon><infon key="fpage">387</infon><infon key="year">1996</infon><infon key="source">Pediatri</infon><infon key="type">ref</infon><infon key="lpage">9</infon><offset>35114</offset><text>Efficacy of oral administration of high-dose cobalamide in a patient with Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Safi;given-names:A</infon><infon key="name_2">surname:Gastin;given-names:I</infon><infon key="name_1">surname:Saunier;given-names:M</infon><infon key="name_0">surname:Gueant;given-names:JL</infon><infon key="fpage">1622</infon><infon key="issue">6</infon><infon key="pub-id_pmid">7768365</infon><infon key="year">1995</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="section_type">REF</infon><infon key="lpage">8</infon><infon key="name_5">surname:Duclos;given-names:B</infon><infon key="name_4">surname:Lamireau;given-names:T</infon><offset>35216</offset><text>Decreased activity of intestinal and urinary intrinsic factor in Grasbeck-Imerslund disease</text></passage><passage><infon key="name_3">surname:Mathan;given-names:VI</infon><infon key="name_2">surname:Trier;given-names:JS</infon><infon key="name_1">surname:Donaldson;given-names:RMJ</infon><infon key="name_0">surname:Mackenzie;given-names:IL</infon><infon key="fpage">1021</infon><infon key="issue">19</infon><infon key="pub-id_pmid">5016373</infon><infon key="year">1972</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">286</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><offset>35309</offset><text>Ileal mucosa in familial selective vitamin B 12 malabsorption</text></passage><passage><infon key="name_3">surname:Erduran;given-names:E</infon><infon key="name_2">surname:Aynaci;given-names:FM</infon><infon key="name_1">surname:Karaguzel;given-names:A</infon><infon key="name_0">surname:Celep;given-names:F</infon><infon key="fpage">248</infon><infon key="issue">4</infon><infon key="pub-id_pmid">9001810</infon><infon key="year">1996</infon><infon key="source">Clin Genet</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="section_type">REF</infon><infon key="lpage">50</infon><offset>35371</offset><text>A case report of 46,XX,del (21)(q22) de novo deletion associated with Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Al Ghanim;given-names:M</infon><infon key="name_2">surname:Sabry;given-names:MA</infon><infon key="name_1">surname:Al Saleh;given-names:Q</infon><infon key="name_0">surname:Ismail;given-names:EAR</infon><infon key="fpage">424</infon><infon key="issue">4</infon><infon key="year">1997</infon><infon key="source">Acta Paediatr Int J Paediatr</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_4">surname:Zaki;given-names:M</infon><offset>35469</offset><text>Genotypic/phenotypic heterogeneity of selective vitamin B12 malabsorption (Grasbeck-Imerslund syndrome) in two Bedouin families</text></passage><passage><infon key="name_3">surname:Baruchel;given-names:A</infon><infon key="name_2">surname:Lesesve;given-names:JF</infon><infon key="name_1">surname:Schneider;given-names:P</infon><infon key="name_0">surname:Flechelles;given-names:O</infon><infon key="fpage">862</infon><infon key="pub-id_pmid">9345569</infon><infon key="year">1997</infon><infon key="source">Arch Pediatr</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="section_type">REF</infon><infon key="lpage">6</infon><infon key="name_5">surname:Tron;given-names:P</infon><infon key="name_4">surname:Vannier;given-names:JP</infon><offset>35597</offset><text>Maladie d' Imerslund. Aspects cliniques et biologiques. A propos de six cas</text></passage><passage><infon key="name_3">surname:Puntis;given-names:JWL</infon><infon key="name_2">surname:Seetharam;given-names:B</infon><infon key="name_1">surname:Livingston;given-names:JH</infon><infon key="name_0">surname:Eaton;given-names:DM</infon><infon key="fpage">173</infon><infon key="issue">1</infon><infon key="pub-id_pmid">9649473</infon><infon key="year">1998</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">115</infon><infon key="section_type">REF</infon><infon key="lpage">6</infon><offset>35675</offset><text>Overexpression of an unstable intrinsic factor-cobalamin receptor in Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Joshi;given-names:S</infon><infon key="name_2">surname:Dabbagh;given-names:O</infon><infon key="name_1">surname:Sakati;given-names:NA</infon><infon key="name_0">surname:Al Essa;given-names:M</infon><infon key="fpage">239</infon><infon key="issue">5</infon><infon key="pub-id_pmid">9620017</infon><infon key="year">1998</infon><infon key="source">J Child Neurol</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="section_type">REF</infon><infon key="lpage">43</infon><infon key="name_5">surname:Rashed;given-names:MS</infon><infon key="name_4">surname:Al Jishi;given-names:EA</infon><offset>35772</offset><text>Inborn error of vitamin B12 metabolism: a treatable cause of childhood dementia/paralysis</text></passage><passage><infon key="volume">45</infon><infon key="name_1">surname:Ferreira;given-names:M</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Stones;given-names:DK</infon><infon key="fpage">106</infon><infon key="issue">2</infon><infon key="pub-id_pmid">10341506</infon><infon key="year">1999</infon><infon key="source">J Trop Pediatr</infon><infon key="type">ref</infon><infon key="lpage">7</infon><offset>35862</offset><text>Imerslund-Grasbeck syndrome in an african patient</text></passage><passage><infon key="name_3">surname:Nuhoglu;given-names:A</infon><infon key="volume">36</infon><infon key="name_2">surname:Kayaoglu;given-names:S</infon><infon key="name_1">surname:Sezgin;given-names:B</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Karatekin;given-names:G</infon><infon key="fpage">1262</infon><infon key="pub-id_pmid">10745371</infon><infon key="year">1999</infon><infon key="source">Indian Pediatr</infon><infon key="type">ref</infon><infon key="lpage">4</infon><offset>35913</offset><text>Imerslund-Grasbeck Syndrome</text></passage><passage><infon key="name_3">surname:Johnson;given-names:C</infon><infon key="name_2">surname:Chadwick;given-names:RB</infon><infon key="name_1">surname:Carter;given-names:JE</infon><infon key="name_0">surname:Aminoff;given-names:M</infon><infon key="fpage">309</infon><infon key="issue">3</infon><infon key="pub-id_pmid">10080186</infon><infon key="year">1999</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="section_type">REF</infon><infon key="lpage">13</infon><infon key="name_5">surname:Abdelaal;given-names:MA</infon><infon key="name_4">surname:Grasbeck;given-names:R</infon><offset>35941</offset><text>Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1</text><annotation id="14603"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="35954" length="4" /><text>CUBN</text></annotation><annotation id="14604"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="36012" length="7" /><text>cubilin</text></annotation></passage><passage><infon key="name_3">surname:Dugue;given-names:B</infon><infon key="name_2">surname:Aminoff;given-names:M</infon><infon key="name_1">surname:Pettersson;given-names:T</infon><infon key="name_0">surname:Wahlstedt-Froberg;given-names:V</infon><infon key="fpage">417</infon><infon key="issue">5</infon><infon key="pub-id_pmid">12687456</infon><infon key="year">2003</infon><infon key="source">Pediatr Nephrol</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><infon key="lpage">21</infon><infon key="name_4">surname:Grasbeck;given-names:R</infon><offset>36062</offset><text>Proteinuria in cubilin-deficient patients with selective vitamin B12 malabsorption</text><annotation id="14605"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="36077" length="7" /><text>cubilin</text></annotation></passage><passage><infon key="name_3">surname:Malvezzi;given-names:M</infon><infon key="name_2">surname:Delle;given-names:LAB</infon><infon key="name_1">surname:Strapasson;given-names:E</infon><infon key="name_0">surname:Bonfin;given-names:C</infon><infon key="fpage">477</infon><infon key="issue">6</infon><infon key="pub-id_pmid">14685505</infon><infon key="year">1999</infon><infon key="source">J Pediatr (Rio J)</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="section_type">REF</infon><infon key="lpage">80</infon><infon key="name_5">surname:Arthur;given-names:G</infon><infon key="name_4">surname:Vaneuza;given-names:A</infon><offset>36145</offset><text>Imerslund-Grasbeck-syndroom: rapport van twee gevallen</text></passage><passage><infon key="volume">124</infon><infon key="name_1">surname:Koch;given-names:HF</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Walters;given-names:TR</infon><infon key="fpage">766</infon><infon key="issue">5</infon><infon key="pub-id_pmid">5085489</infon><infon key="year">1972</infon><infon key="source">Am J Dis Child</infon><infon key="type">ref</infon><infon key="lpage">8</infon><offset>36201</offset><text>Generalized malabsorption, failure to thrive and megaloblastic anemia. Result of cyanocobalamin deficiency</text></passage><passage><infon key="name_3">surname:Freeman;given-names:S</infon><infon key="name_2">surname:Franco;given-names:I</infon><infon key="name_1">surname:Bolten;given-names:P</infon><infon key="name_0">surname:Sandoval;given-names:C</infon><infon key="fpage">331</infon><infon key="issue">4</infon><infon key="pub-id_pmid">10845232</infon><infon key="year">2000</infon><infon key="source">Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="section_type">REF</infon><infon key="lpage">4</infon><infon key="name_4">surname:Jayabose;given-names:S</infon><offset>36308</offset><text>Recurrent urinary tract infections and genitourinary tract abnormalities in the Imerslund-Grasbeck syndrome</text></passage><passage><infon key="volume">212</infon><infon key="name_2">surname:Eber;given-names:S</infon><infon key="name_1">surname:Witt;given-names:O</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Schroder;given-names:A</infon><infon key="fpage">22</infon><infon key="issue">1</infon><infon key="pub-id_pmid">10719679</infon><infon key="year">2000</infon><infon key="source">Klin Padiatr</infon><infon key="type">ref</infon><infon key="lpage">5</infon><offset>36416</offset><text>Diabetes mellitus typ I, zoliakie und imerslund-Grasbeck-syndrom: Nur eine ungewohnliche kombination seltener erkrankungen?</text></passage><passage><infon key="name_3">surname:Kilic;given-names:H</infon><infon key="volume">6</infon><infon key="name_2">surname:Gurgoze;given-names:MK</infon><infon key="name_1">surname:Aygun;given-names:AD</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Sen;given-names:C</infon><infon key="fpage">393</infon><infon key="issue">2</infon><infon key="year">2001</infon><infon key="source">Firat Tip Derg Firat Med J</infon><infon key="type">ref</infon><infon key="lpage">5</infon><offset>36540</offset><text>Imerslund-Grasbeck syndrome: a Case Report</text></passage><passage><infon key="name_3">surname:El-Shanti;given-names:HI</infon><infon key="name_2">surname:Al-Sheyyab;given-names:MY</infon><infon key="name_1">surname:Tayeh;given-names:MK</infon><infon key="name_0">surname:Al-Alami;given-names:JR</infon><infon key="fpage">1251</infon><infon key="issue">10</infon><infon key="pub-id_pmid">12436132</infon><infon key="year">2002</infon><infon key="source">Saudi Med J</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="section_type">REF</infon><infon key="lpage">6</infon><offset>36583</offset><text>Linkage analysis of a large inbred family with congenital megaloblastic anemia</text></passage><passage><infon key="volume">162</infon><infon key="name_2">surname:Havers;given-names:W</infon><infon key="name_1">surname:Breitenstein;given-names:S</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Rossler;given-names:J</infon><infon key="fpage">808</infon><infon key="issue">11</infon><infon key="pub-id_pmid">14593474</infon><infon key="year">2003</infon><infon key="source">Eur J Pediatr</infon><infon key="type">ref</infon><infon key="lpage">9</infon><offset>36662</offset><text>Late onset of Imerslund-Grasbeck syndrome without proteinuria in four children of one family from the Lebanon</text></passage><passage><infon key="name_3">surname:Acar;given-names:C</infon><infon key="name_2">surname:Bisson;given-names:R</infon><infon key="name_1">surname:Li;given-names:Z</infon><infon key="name_0">surname:Tanner;given-names:SM</infon><infon key="fpage">327</infon><infon key="issue">4</infon><infon key="pub-id_pmid">15024727</infon><infon key="year">2004</infon><infon key="source">Hum Mutat</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="section_type">REF</infon><infon key="lpage">33</infon><infon key="name_5">surname:Oner;given-names:R</infon><infon key="name_4">surname:Oner;given-names:C</infon><offset>36773</offset><text>Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder Effects, Consanguinity, and high clinical awareness explain Aggregations in Scandinavia and the Middle East</text></passage><passage><infon key="name_3">surname:Altay;given-names:C</infon><infon key="name_2">surname:Aytac;given-names:S</infon><infon key="name_1">surname:Cetin;given-names:M</infon><infon key="name_0">surname:Bor;given-names:MV</infon><infon key="fpage">2151</infon><infon key="issue">11</infon><infon key="pub-id_pmid">16166166</infon><infon key="year">2005</infon><infon key="source">Clin Chem</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_4">surname:Nexo;given-names:E</infon><offset>36966</offset><text>Nonradioactive vitamin B12 absorption test evaluated in controls and in patients with inherited malabsorption of vitamin B12</text></passage><passage><infon key="name_3">surname:de la Chapelle;given-names:A</infon><infon key="name_2">surname:Tayeh;given-names:MK</infon><infon key="name_1">surname:Tanner;given-names:SM</infon><infon key="name_0">surname:Al-Alami;given-names:JR</infon><infon key="fpage">1061</infon><infon key="issue">7</infon><infon key="pub-id_pmid">16047053</infon><infon key="year">2005</infon><infon key="source">Saudi Med J</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="section_type">REF</infon><infon key="lpage">4</infon><infon key="name_4">surname:El-Shanti;given-names:H</infon><offset>37091</offset><text>Homozygous AMN mutation in hereditary selective intestinal malabsorption of vitamin B12 in Jordan</text><annotation id="14606"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="37102" length="3" /><text>AMN</text></annotation></passage><passage><infon key="name_3">surname:Hadad;given-names:N</infon><infon key="name_2">surname:Levy;given-names:R</infon><infon key="name_1">surname:Yerushalmi;given-names:B</infon><infon key="name_0">surname:Broides;given-names:A</infon><infon key="fpage">715</infon><infon key="issue">11</infon><infon key="pub-id_pmid">17114957</infon><infon key="year">2006</infon><infon key="source">J Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="section_type">REF</infon><infon key="lpage">9</infon><infon key="name_5">surname:Tanner;given-names:SM</infon><infon key="name_4">surname:Kaplun;given-names:N</infon><offset>37189</offset><text>Imerslund-Grasbeck syndrome associated with recurrent aphthous stomatitis and defective neutrophil function</text></passage><passage><infon key="name_3">surname:Ayadi;given-names:A</infon><infon key="name_2">surname:Mahjoub;given-names:B</infon><infon key="name_1">surname:Maktouf;given-names:C</infon><infon key="name_0">surname:Bouchlaka;given-names:C</infon><infon key="fpage">262</infon><infon key="issue">3</infon><infon key="pub-id_pmid">17285242</infon><infon key="year">2007</infon><infon key="source">J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="section_type">REF</infon><infon key="lpage">70</infon><infon key="name_5">surname:Sioud;given-names:M</infon><infon key="name_4">surname:Sfar;given-names:MT</infon><offset>37297</offset><text>Genetic heterogeneity of megaloblastic anaemia type 1 in tunisian patients</text></passage><passage><infon key="name_3">surname:Green;given-names:R</infon><infon key="name_2">surname:Cassel;given-names:R</infon><infon key="name_1">surname:Geefhuysen;given-names:J</infon><infon key="name_0">surname:Buchanan;given-names:N</infon><infon key="fpage">153</infon><infon key="issue">2</infon><infon key="pub-id_pmid">4773963</infon><infon key="year">1973</infon><infon key="source">Scand J Haematol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="lpage">7</infon><offset>37372</offset><text>Selective malabsorption of vitamin B12 in a Negro boy</text></passage><passage><infon key="name_3">surname:Walter;given-names:JH</infon><infon key="name_2">surname:de la Chapelle;given-names:A</infon><infon key="name_1">surname:Tanner;given-names:SM</infon><infon key="name_0">surname:Luder;given-names:AS</infon><infon key="fpage">493</infon><infon key="issue">Suppl 3</infon><infon key="pub-id_pmid">18181028</infon><infon key="year">2008</infon><infon key="source">J Inherit Metab Dis</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="section_type">REF</infon><infon key="lpage">6</infon><offset>37426</offset><text>Amnionless (AMN) mutations in Imerslund-Grasbeck syndrome may be associated with disturbed vitamin B12 transport into the CNS</text><annotation id="14607"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="37438" length="3" /><text>AMN</text></annotation><annotation id="14608"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="37426" length="10" /><text>Amnionless</text></annotation></passage><passage><infon key="name_3">surname:Laass;given-names:MW</infon><infon key="name_2">surname:Henker;given-names:J</infon><infon key="name_1">surname:Tanner;given-names:SM</infon><infon key="name_0">surname:Hauck;given-names:FH</infon><infon key="fpage">671</infon><infon key="issue">6</infon><infon key="pub-id_pmid">17668238</infon><infon key="year">2008</infon><infon key="source">Eur J Pediatr</infon><infon key="type">ref</infon><infon key="volume">167</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><offset>37555</offset><text>Imerslund-Grasbeck syndrome in a 15-year-old german girl caused by compound heterozygous mutations in CUBN</text><annotation id="14609"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="37657" length="4" /><text>CUBN</text></annotation></passage><passage><infon key="name_3">surname:Nammalwar;given-names:BR</infon><infon key="name_2">surname:Rajajee;given-names:S</infon><infon key="name_1">surname:Vijayakumar;given-names:M</infon><infon key="name_0">surname:Madhavan;given-names:S</infon><infon key="fpage">251</infon><infon key="issue">3</infon><infon key="pub-id_pmid">19346573</infon><infon key="year">2009</infon><infon key="source">Indian Pediatr</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="section_type">REF</infon><infon key="lpage">3</infon><offset>37663</offset><text>Imerslund-grasbeck syndrome: Association with diabetes mellitus</text></passage><passage><infon key="name_3">surname:Vianney;given-names:C</infon><infon key="name_2">surname:Pondarre;given-names:C</infon><infon key="name_1">surname:Levrat;given-names:V</infon><infon key="name_0">surname:Choquet;given-names:P</infon><infon key="fpage">1559</infon><infon key="pub-id_pmid">19854032</infon><infon key="year">2009</infon><infon key="source">Arch Pediatr</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="lpage">61</infon><infon key="name_4">surname:Guffon;given-names:N</infon><offset>37727</offset><text>Maladie d'Imerslund-Grasbeck</text></passage><passage><infon key="name_3">surname:Curgey;given-names:A</infon><infon key="name_2">surname:Cumruk;given-names:F</infon><infon key="name_1">surname:Basak;given-names:AN</infon><infon key="name_0">surname:Sayli;given-names:TR</infon><infon key="fpage">223</infon><infon key="issue">2</infon><infon key="pub-id_pmid">8204449</infon><infon key="year">1994</infon><infon key="source">Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_4">surname:Altay;given-names:C</infon><offset>37758</offset><text>Imerslund-grasbeck syndrome coexisting with p-thalassemia trait</text></passage><passage><infon key="name_3">surname:Audonnet;given-names:S</infon><infon key="name_2">surname:Chery;given-names:C</infon><infon key="name_1">surname:Dobrovoljski;given-names:G</infon><infon key="name_0">surname:Namour;given-names:F</infon><infon key="fpage">1715</infon><infon key="issue">11</infon><infon key="pub-id_pmid">21750092</infon><infon key="year">2011</infon><infon key="source">Haematologica</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="section_type">REF</infon><infon key="lpage">9</infon><infon key="name_5">surname:Sper;given-names:W</infon><infon key="name_4">surname:Feillet;given-names:F</infon><offset>37822</offset><text>Luminal expression of cubilin is impaired in imerslund-grasbeck syndrome with compound AMN mutations in intron 3 and exon 7</text><annotation id="14610"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="37909" length="3" /><text>AMN</text></annotation><annotation id="14611"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="37844" length="7" /><text>cubilin</text></annotation></passage><passage><infon key="name_3">surname:Hertz;given-names:JM</infon><infon key="name_2">surname:Verroust;given-names:PJ</infon><infon key="name_1">surname:Emma;given-names:F</infon><infon key="name_0">surname:Storm;given-names:T</infon><infon key="fpage">89</infon><infon key="issue">1</infon><infon key="pub-id_pmid">21208123</infon><infon key="year">2011</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">364</infon><infon key="section_type">REF</infon><infon key="lpage">91</infon><infon key="name_5">surname:Christensen;given-names:EI</infon><infon key="name_4">surname:Nielsen;given-names:R</infon><offset>37947</offset><text>A patient with Cubilin Deficiency</text><annotation id="14612"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="37962" length="7" /><text>Cubilin</text></annotation></passage><passage><infon key="name_3">surname:Ganon;given-names:L</infon><infon key="name_2">surname:Morduchowicz;given-names:G</infon><infon key="name_1">surname:Dinour;given-names:D</infon><infon key="name_0">surname:Levin-Iaina;given-names:N</infon><infon key="fpage">67</infon><infon key="issue">2</infon><infon key="year">2011</infon><infon key="source">Nephron Clin Pract</infon><infon key="type">ref</infon><infon key="volume">118</infon><infon key="section_type">REF</infon><infon key="lpage">71</infon><infon key="name_4">surname:Holtzman;given-names:EJ</infon><offset>37981</offset><text>Molecular study of proteinuria in patients treated with B12 supplements: do not forget megaloblastic anemia type 1</text></passage><passage><infon key="name_3">surname:Saisawat;given-names:P</infon><infon key="name_2">surname:Vega-Warner;given-names:V</infon><infon key="name_1">surname:Otto;given-names:EA</infon><infon key="name_0">surname:Ovunc;given-names:B</infon><infon key="fpage">1815</infon><infon key="issue">10</infon><infon key="pub-id_pmid">21903995</infon><infon key="year">2011</infon><infon key="source">J Am Soc Nephrol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="section_type">REF</infon><infon key="lpage">20</infon><infon key="name_5">surname:Ramaswami;given-names:G</infon><infon key="name_4">surname:Ashraf;given-names:S</infon><offset>38096</offset><text>Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria</text><annotation id="14613"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="38121" length="7" /><text>cubilin</text></annotation></passage><passage><infon key="name_3">surname:Permi;given-names:HS</infon><infon key="name_2">surname:Shetty;given-names:JK</infon><infon key="name_1">surname:Yeshvanth;given-names:SK</infon><infon key="name_0">surname:Laxminarayana;given-names:KPH</infon><infon key="fpage">113</infon><infon key="issue">02</infon><infon key="pub-id_pmid">22219566</infon><infon key="year">2011</infon><infon key="source">J Lab Physicians</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_4">surname:Rao;given-names:C</infon><offset>38176</offset><text>Unusual cause of Childhood Anemia: Imerslund Grasbeck Syndrome</text></passage><passage><infon key="volume">11</infon><infon key="name_1">surname:Nevanlinna;given-names:HR</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Furuhjelm;given-names:U</infon><infon key="fpage">27</infon><infon key="issue">1</infon><infon key="pub-id_pmid">4756428</infon><infon key="year">1973</infon><infon key="source">Scand J Haematol</infon><infon key="type">ref</infon><infon key="lpage">34</infon><offset>38239</offset><text>Inheritance of selective malabsorption of vitamin B12</text></passage><passage><infon key="volume">31</infon><infon key="name_2">surname:Banerjee;given-names:A</infon><infon key="name_1">surname:Nayek;given-names:K</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ghosh;given-names:TN</infon><infon key="fpage">249</infon><infon key="issue">3</infon><infon key="year">2011</infon><infon key="source">J Nepal Paediatr Soc</infon><infon key="type">ref</infon><infon key="lpage">50</infon><offset>38293</offset><text>Imerslund-Grasbeck syndrome: a Case Report</text></passage><passage><infon key="name_3">surname:Balkan;given-names:C</infon><infon key="volume">23</infon><infon key="name_2">surname:Mir;given-names:S</infon><infon key="name_1">surname:Mutlubas;given-names:F</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Bulut;given-names:I</infon><infon key="fpage">569</infon><infon key="issue">3</infon><infon key="year">2012</infon><infon key="source">Saoudi J Kidney Dis Transplant</infon><infon key="type">ref</infon><infon key="lpage">71</infon><offset>38336</offset><text>An infant with Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Passemard;given-names:S</infon><infon key="name_2">surname:Kozyraki;given-names:R</infon><infon key="name_1">surname:Ogier de Baulny;given-names:H</infon><infon key="name_0">surname:Boina Abdallah;given-names:A</infon><infon key="fpage">66</infon><infon key="issue">1-2</infon><infon key="pub-id_pmid">22854512</infon><infon key="year">2012</infon><infon key="source">Mol Genet Metab</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="section_type">REF</infon><infon key="lpage">71</infon><infon key="name_5">surname:Lebon;given-names:S</infon><infon key="name_4">surname:Fenneteau;given-names:O</infon><offset>38379</offset><text>How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B12 absorption?</text></passage><passage><infon key="name_3">surname:Pattaragarn;given-names:A</infon><infon key="name_2">surname:Vijarnsorn;given-names:C</infon><infon key="name_1">surname:Sanpakit;given-names:K</infon><infon key="name_0">surname:Densupsoontorn;given-names:N</infon><infon key="fpage">19</infon><infon key="issue">3</infon><infon key="pub-id_pmid">21810153</infon><infon key="year">2012</infon><infon key="source">Pediatr Int</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="section_type">REF</infon><infon key="lpage">21</infon><infon key="name_5">surname:Jatutipsompol;given-names:C</infon><infon key="name_4">surname:Kangwanpornsiri;given-names:C</infon><offset>38484</offset><text>Imerslund-Grasbeck syndrome: New mutation in amnionless</text><annotation id="14614"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="38529" length="10" /><text>amnionless</text></annotation></passage><passage><infon key="name_3">surname:Liyanarachchi;given-names:S</infon><infon key="name_2">surname:Wright;given-names:FA</infon><infon key="name_1">surname:Aminoff;given-names:M</infon><infon key="name_0">surname:Tanner;given-names:SM</infon><infon key="fpage">426</infon><infon key="issue">3</infon><infon key="pub-id_pmid">12590260</infon><infon key="year">2003</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="section_type">REF</infon><infon key="lpage">9</infon><infon key="name_5">surname:Saarinen;given-names:A</infon><infon key="name_4">surname:Kuronen;given-names:M</infon><offset>38541</offset><text>Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia</text><annotation id="14615"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="38541" length="10" /><text>Amnionless</text></annotation></passage><passage><infon key="name_3">surname:Sturm;given-names:AC</infon><infon key="name_2">surname:Shah;given-names:NP</infon><infon key="name_1">surname:Liyanarachchi;given-names:S</infon><infon key="name_0">surname:Beech;given-names:CM</infon><infon key="fpage">74</infon><infon key="issue">1</infon><infon key="pub-id_pmid">22078000</infon><infon key="year">2011</infon><infon key="source">Orphanet J Rare Dis</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="section_type">REF</infon><infon key="name_5">surname:De La Chapelle;given-names:A</infon><infon key="name_4">surname:Sadiq;given-names:MF</infon><offset>38643</offset><text>Ancient founder mutation is responsible for Imerslund-Grasbeck syndrome among diverse ethnicities</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>38742</offset><text>Storm T, Zeitz C, Cases O, Amsellem S, Verroust PJ, Madsen M et al. Detailed investigations of proximal tubular function in Imerslund-Grasbeck syndrome. BMC Med Genet. 2013;14(1).</text></passage><passage><infon key="volume">3</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Shetty;given-names:GM</infon><infon key="fpage">56</infon><infon key="issue">1</infon><infon key="year">2012</infon><infon key="source">Int J Biomed Res</infon><infon key="type">ref</infon><infon key="lpage">7</infon><offset>38923</offset><text>Pancytopenia with Proteinuria - Imerslund Grasbeck Syndrome</text></passage><passage><infon key="name_3">surname:Shah;given-names:NP</infon><infon key="name_2">surname:Beech;given-names:CM</infon><infon key="name_1">surname:Ansari;given-names:A</infon><infon key="name_0">surname:Siddiqui;given-names:AH</infon><infon key="fpage">140</infon><infon key="issue">2</infon><infon key="pub-id_pmid">22082743</infon><infon key="year">2012</infon><infon key="source">J Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="section_type">REF</infon><infon key="lpage">2</infon><infon key="name_5">surname:Sarnaik;given-names:SA</infon><infon key="name_4">surname:Tanner;given-names:SM</infon><offset>38985</offset><text>Juvenile Cobalamin Deficiency in a 17 Year Old child with autonomic dysfunction and skin changes</text></passage><passage><infon key="name_3">surname:Ingec;given-names:M</infon><infon key="name_2">surname:Ulas;given-names:T</infon><infon key="name_1">surname:Demir;given-names:ME</infon><infon key="name_0">surname:Ercan;given-names:Z</infon><infon key="fpage">147</infon><infon key="issue">1</infon><infon key="pub-id_pmid">23364648</infon><infon key="year">2013</infon><infon key="source">Nefrologia</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="section_type">REF</infon><infon key="lpage">8</infon><infon key="name_4">surname:Horoz;given-names:M</infon><offset>39082</offset><text>A long-term follow-up of an imerslund-grasbeck syndrome patient with proteinuria</text></passage><passage><infon key="volume">18</infon><infon key="name_2">surname:Krivit;given-names:W</infon><infon key="name_1">surname:Greenberg;given-names:L</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Colle;given-names:E</infon><infon key="fpage">48</infon><infon key="pub-id_pmid">13694674</infon><infon key="year">1961</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="lpage">60</infon><offset>39163</offset><text>Studies of a patient with selective deficiency in absorption of vitamin B12</text></passage><passage><infon key="name_3">surname:Esposito;given-names:T</infon><infon key="name_2">surname:Rocco;given-names:V</infon><infon key="name_1">surname:Rendina;given-names:D</infon><infon key="name_0">surname:De Filippo;given-names:G</infon><infon key="fpage">2</infon><infon key="issue">1</infon><infon key="pub-id_pmid">23321150</infon><infon key="year">2013</infon><infon key="source">Ital J Pediatr</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_5">surname:Strazzullo;given-names:P</infon><infon key="name_4">surname:Gianfrancesco;given-names:F</infon><offset>39239</offset><text>Imerslund-Grasbeck syndrome in a 25-month-old italian girl caused by a homozygous mutation in AMN</text><annotation id="14616"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="39333" length="3" /><text>AMN</text></annotation></passage><passage><infon key="volume">50</infon><infon key="name_1">surname:Srinath;given-names:M</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Shivbalan;given-names:S</infon><infon key="fpage">973</infon><infon key="pub-id_pmid">24222293</infon><infon key="year">2013</infon><infon key="source">Indian Pediatr</infon><infon key="type">ref</infon><infon key="lpage">4</infon><offset>39338</offset><text>Reversible skin hyperpigmentation in Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Yano;given-names:S</infon><infon key="name_2">surname:McGuire;given-names:E</infon><infon key="name_1">surname:Thomas;given-names:M</infon><infon key="name_0">surname:Ho;given-names:CH</infon><infon key="fpage">926</infon><infon key="issue">11</infon><infon key="pub-id_pmid">24906012</infon><infon key="year">2014</infon><infon key="source">J Paediatr Child Health</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="section_type">REF</infon><infon key="lpage">8</infon><offset>39403</offset><text>2-year-old girl with pancytopenia due to vitamin B12 (cobalamin) deficiency</text></passage><passage><infon key="name_3">surname:Hynes;given-names:MA</infon><infon key="name_2">surname:Baines;given-names:LA</infon><infon key="name_1">surname:Sayer;given-names:JA</infon><infon key="name_0">surname:Montgomery;given-names:E</infon><infon key="fpage">2</infon><infon key="issue">1</infon><infon key="pub-id_pmid">25648141</infon><infon key="year">2015</infon><infon key="source">BMC Med Genet</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_5">surname:Johnson;given-names:S</infon><infon key="name_4">surname:Vega-Warner;given-names:V</infon><offset>39479</offset><text>Novel compound heterozygous mutations in AMN cause Imerslund-Grasbeck syndrome in two half-sisters: a case report</text><annotation id="14617"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="39520" length="3" /><text>AMN</text></annotation></passage><passage><infon key="name_3">surname:Ahmadi;given-names:MA</infon><infon key="volume">26</infon><infon key="name_2">surname:Behnam;given-names:B</infon><infon key="name_1">surname:Zavvar;given-names:N</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Goudarzipour;given-names:K</infon><infon key="fpage">455</infon><infon key="pub-id_pmid">27942180</infon><infon key="year">2016</infon><infon key="source">Indian J Nephrol</infon><infon key="type">ref</infon><infon key="lpage">7</infon><offset>39594</offset><text>Imerslund-Grasbeck syndrome in a 5-year-old iranian boy</text></passage><passage><infon key="name_3">surname:Lionetti;given-names:ME</infon><infon key="volume">48</infon><infon key="name_2">surname:Albano;given-names:V</infon><infon key="name_1">surname:Marabini;given-names:C</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Del Baldo;given-names:G</infon><infon key="fpage">e274</infon><infon key="issue">2016</infon><infon key="year">2016</infon><infon key="source">Dig Liver Dis</infon><infon key="type">ref</infon><infon key="name_4">surname:Gatti;given-names:S</infon><offset>39650</offset><text>Imerslund-Grasbeck Syndrome (selective B12 malabsorption): think about it also in Down's syndrome!</text></passage><passage><infon key="name_3">surname:Pinxteren-Nagler;given-names:E</infon><infon key="name_2">surname:Bruin;given-names:M</infon><infon key="name_1">surname:De Schryver;given-names:J</infon><infon key="name_0">surname:Wulffraat;given-names:NM</infon><infon key="fpage">177</infon><infon key="issue">2</infon><infon key="pub-id_pmid">8166372</infon><infon key="year">1994</infon><infon key="source">Am J Pediatr Hematol Oncol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="lpage">80</infon><infon key="name_4">surname:van Dijken;given-names:PJ</infon><offset>39753</offset><text>Failure to thrive is an early symptom of the imerslund Grasbeck syndrome</text></passage><passage><infon key="volume">5</infon><infon key="name_2">surname:Kandula;given-names:KG</infon><infon key="name_1">surname:Bhat;given-names:KSA</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Kamath;given-names:SJ</infon><infon key="fpage">67</infon><infon key="issue">4</infon><infon key="year">2017</infon><infon key="source">JCRS Online Case Reports</infon><infon key="type">ref</infon><infon key="lpage">8</infon><offset>39827</offset><text>Imerslund-Grasbeck syndrome with developmental cataract</text></passage><passage><infon key="volume">6</infon><infon key="name_2">surname:Pandey;given-names:D</infon><infon key="name_1">surname:Chand;given-names:S</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Agarwal;given-names:P</infon><infon key="fpage">228</infon><infon key="issue">4</infon><infon key="year">2017</infon><infon key="source">Int J Heal Allied Sci</infon><infon key="type">ref</infon><infon key="lpage">9</infon><offset>39884</offset><text>Imerslund - Grasbeck syndrome presented as pancytopenia: a rare case report</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>39962</offset><text>Faatovna AE, Dmitrievna SN. Clinical observance : of Megaloblastic Anemia with B12 Deficiency and Proteinuria in Imerslund-Grasbeck Syndrome. materialy kongressa &lt;&lt;Zdorovye deti : budushchee strany&gt;&gt;. 2017;12:21-2.</text></passage><passage><infon key="name_3">surname:Afifi;given-names:F</infon><infon key="volume">77</infon><infon key="name_2">surname:Loverdo;given-names:A</infon><infon key="name_1">surname:Besancon;given-names:F</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Lamy;given-names:M</infon><infon key="fpage">1107</infon><infon key="pub-id_pmid">14461867</infon><infon key="year">1961</infon><infon key="source">Bull Mem Soc Med Hop Paris</infon><infon key="type">ref</infon><infon key="lpage">11</infon><offset>40223</offset><text>4 cases of a new infantile megaloblastic anemia: the specific malaborption of vitamin B 12 with proteinuria of Imerslund-Najman-Grasbeck</text></passage><passage><infon key="volume">131</infon><infon key="name_1">surname:Li;given-names:W</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Goubeaux;given-names:DL</infon><infon key="fpage">153</infon><infon key="issue">1</infon><infon key="pub-id_pmid">29301775</infon><infon key="year">2018</infon><infon key="source">Blood</infon><infon key="type">ref</infon><offset>40360</offset><text>Cabot rings and marked anisopoikilocytosis in Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Grunewald;given-names:S</infon><infon key="name_2">surname:Banka;given-names:S</infon><infon key="name_1">surname:Furman;given-names:M</infon><infon key="name_0">surname:Ciancio;given-names:JIR</infon><infon key="fpage">43</infon><infon key="issue">1</infon><infon key="pub-id_pmid">31497480</infon><infon key="year">2019</infon><infon key="source">JIMD Rep</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="section_type">REF</infon><infon key="lpage">7</infon><offset>40435</offset><text>Profound vitamin D deficiency in four siblings with Imerslund-Grasbeck syndrome with homozygous CUBN mutation</text><annotation id="14618"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="40531" length="4" /><text>CUBN</text></annotation></passage><passage><infon key="name_3">surname:Stefanelli;given-names:M</infon><infon key="name_2">surname:Stangoni;given-names:G</infon><infon key="name_1">surname:Prontera;given-names:P</infon><infon key="name_0">surname:Pacitto;given-names:A</infon><infon key="fpage">3</infon><infon key="issue">3</infon><infon key="year">2019</infon><infon key="source">Int J Mol Sci</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="lpage">7</infon><infon key="name_5">surname:Cerri;given-names:C</infon><infon key="name_4">surname:Ceppi;given-names:S</infon><offset>40545</offset><text>Imerslund-Grasbeck syndrome in an infant with a novel intronic variant in the AMN gene: a case report</text><annotation id="14619"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="40623" length="3" /><text>AMN</text></annotation></passage><passage><infon key="name_3">surname:MacGregor;given-names:D</infon><infon key="name_2">surname:Kerr;given-names:PG</infon><infon key="name_1">surname:White;given-names:SM</infon><infon key="name_0">surname:Jayasinghe;given-names:K</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="pub-id_pmid">30606155</infon><infon key="year">2019</infon><infon key="source">BMC Nephrol</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_5">surname:Wilkins;given-names:E</infon><infon key="name_4">surname:Stark;given-names:Z</infon><offset>40648</offset><text>Isolated proteinuria due to CUBN homozygous mutation - challenging the investigative paradigm</text><annotation id="14620"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="40676" length="4" /><text>CUBN</text></annotation></passage><passage><infon key="volume">63</infon><infon key="name_2">surname:Cavdarli;given-names:B</infon><infon key="name_1">surname:Akpinar Tekgunduz;given-names:S</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Gurlek Gokcebay;given-names:D</infon><infon key="fpage">2</infon><infon key="issue">6</infon><infon key="year">2020</infon><infon key="source">Eur J Med Genet</infon><infon key="type">ref</infon><infon key="lpage">4</infon><offset>40742</offset><text>Imerslund-Grasbeck Syndrome presenting with microangiopathic hemolytic anemia in a child</text></passage><passage><infon key="name_3">surname:Li;given-names:Y</infon><infon key="name_2">surname:Servais;given-names:A</infon><infon key="name_1">surname:Boyer;given-names:O</infon><infon key="name_0">surname:Bedin;given-names:M</infon><infon key="fpage">335</infon><infon key="issue">1</infon><infon key="pub-id_pmid">31613795</infon><infon key="year">2020</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">130</infon><infon key="section_type">REF</infon><infon key="lpage">44</infon><infon key="name_5">surname:Tete;given-names:MJ</infon><infon key="name_4">surname:Villoing-Gaude;given-names:L</infon><offset>40832</offset><text>Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function</text><annotation id="14621"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="40849" length="4" /><text>CUBN</text></annotation></passage><passage><infon key="volume">191</infon><infon key="name_1">surname:Crazzolara;given-names:R</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Bargehr;given-names:C</infon><infon key="fpage">11</infon><infon key="issue">1</infon><infon key="pub-id_pmid">32613615</infon><infon key="year">2020</infon><infon key="source">Br J Haematol</infon><infon key="type">ref</infon><offset>40924</offset><text>Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome</text></passage><passage><infon key="name_3">surname:Mitsui;given-names:J</infon><infon key="name_2">surname:Miura;given-names:K</infon><infon key="name_1">surname:Harita;given-names:Y</infon><infon key="name_0">surname:Udagawa;given-names:T</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="pub-id_pmid">29311619</infon><infon key="year">2018</infon><infon key="source">Sci Rep</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="section_type">REF</infon><infon key="lpage">12</infon><infon key="name_5">surname:Morishita;given-names:S</infon><infon key="name_4">surname:Ode;given-names:KL</infon><offset>41006</offset><text>Amnionless-mediated glycosylation is crucial for cell surface targeting of cubilin in renal and intestinal cells</text><annotation id="14622"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="41006" length="10" /><text>Amnionless</text></annotation><annotation id="14623"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="41081" length="7" /><text>cubilin</text></annotation></passage><passage><infon key="name_3">surname:Al-Thihli;given-names:KA</infon><infon key="name_2">surname:Al-Nabhani;given-names:DM</infon><infon key="name_1">surname:Gao;given-names:HH</infon><infon key="name_0">surname:Elshinawy;given-names:M</infon><infon key="fpage">1009</infon><infon key="issue">5</infon><infon key="pub-id_pmid">33491342</infon><infon key="year">2021</infon><infon key="source">Int J Lab Hematol</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="section_type">REF</infon><infon key="lpage">15</infon><offset>41119</offset><text>Clinical and molecular characteristics of imerslund-grasbeck syndrome: first report of a novel Frameshift variant in exon 11 of AMN gene</text><annotation id="14624"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="41247" length="3" /><text>AMN</text></annotation></passage><passage><infon key="name_3">surname:Muthukumarana;given-names:O</infon><infon key="name_2">surname:Rathnasri;given-names:A</infon><infon key="name_1">surname:Hoole;given-names:TJ</infon><infon key="name_0">surname:Arunath;given-names:V</infon><infon key="fpage">1</infon><infon key="issue">1</infon><infon key="pub-id_pmid">33397296</infon><infon key="year">2021</infon><infon key="source">BMC Pediatr</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="section_type">REF</infon><infon key="lpage">5</infon><infon key="name_5">surname:Liyanage;given-names:ND</infon><infon key="name_4">surname:Kumarasiri;given-names:IM</infon><offset>41257</offset><text>A child with Imerslund-Grasbeck syndrome concealed by co-existing alpha-thalassaemia presenting with subacute combined degeneration of the spinal cord: a case report</text></passage><passage><infon key="volume">42</infon><infon key="name_1">surname:Baumgartner;given-names:MR</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Huemer;given-names:M</infon><infon key="fpage">686</infon><infon key="issue">4</infon><infon key="pub-id_pmid">30761552</infon><infon key="year">2019</infon><infon key="source">J Inherit Metab Dis</infon><infon key="type">ref</infon><infon key="lpage">705</infon><offset>41423</offset><text>The clinical presentation of cobalamin-related disorders: from acquired deficiencies to inborn errors of absorption and intracellular pathways</text></passage><passage><infon key="name_3">surname:Nexo;given-names:E</infon><infon key="name_2">surname:Hardlei;given-names:T</infon><infon key="name_1">surname:Van De Wetering;given-names:K</infon><infon key="name_0">surname:Beedholm-Ebsen;given-names:R</infon><infon key="fpage">1632</infon><infon key="issue">8</infon><infon key="pub-id_pmid">19897579</infon><infon key="year">2010</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">115</infon><infon key="section_type">REF</infon><infon key="lpage">9</infon><infon key="name_5">surname:Moestrup;given-names:SK</infon><infon key="name_4">surname:Borst;given-names:P</infon><offset>41566</offset><text>Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>41681</offset><text>Hamilton MS, Blackmore S. Chapter 10 - Investigation of megaloblastic anaemia [Internet]. 11th ed. Dacie and Lewis Practical Haematology. Elsevier Ltd.; 2012. 201-228 p.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>41853</offset><text>Watkins D, Rosenblatt DS, Fowler B. Disorders of Cobalamin and Folate Transport and Metabolism. In: Saudubray J-M, Baumgartner MR, Walter JH, editors. Inborn Metabolic Diseases. 6th editio. Springer; 2016. p. 385-99.</text></passage><passage><infon key="volume">42</infon><infon key="name_2">surname:Baumgartner;given-names:MR</infon><infon key="name_1">surname:Fowler;given-names:B</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Froese;given-names:DS</infon><infon key="fpage">673</infon><infon key="issue">4</infon><infon key="pub-id_pmid">30693532</infon><infon key="year">2019</infon><infon key="source">J Inherit Metab Dis</infon><infon key="type">ref</infon><infon key="lpage">85</infon><offset>42073</offset><text>Vitamin B12, folate, and the methionine remethylation cycle:biochemistry, pathways, and regulation</text></passage><passage><infon key="name_3">surname:Madsen;given-names:M</infon><infon key="name_2">surname:Kozyraki;given-names:R</infon><infon key="name_1">surname:Gburek;given-names:J</infon><infon key="name_0">surname:Coudroy;given-names:G</infon><infon key="fpage">2330</infon><infon key="issue">8</infon><infon key="pub-id_pmid">15976000</infon><infon key="year">2005</infon><infon key="source">J Am Soc Nephrol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="lpage">7</infon><infon key="name_5">surname:Moestrup;given-names:SK</infon><infon key="name_4">surname:Trugnan;given-names:G</infon><offset>42174</offset><text>Contribution of cubilin and amnionless to processing and membrane targeting of cubilin-amnionless complex</text><annotation id="14625"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="42261" length="10" /><text>amnionless</text></annotation><annotation id="14626"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="42202" length="10" /><text>amnionless</text></annotation><annotation id="14627"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="42253" length="7" /><text>cubilin</text></annotation><annotation id="14628"><infon key="identifier">8029</infon><infon key="type">Gene</infon><location offset="42190" length="7" /><text>cubilin</text></annotation></passage><passage><infon key="name_3">surname:Linarelli;given-names:LG</infon><infon key="name_2">surname:Macdonald;given-names:RR</infon><infon key="name_1">surname:Giorgio;given-names:AJ</infon><infon key="name_0">surname:Rubin;given-names:HM</infon><infon key="fpage">713</infon><infon key="issue">5</infon><infon key="pub-id_pmid">4825590</infon><infon key="year">1974</infon><infon key="source">Am J Dis Child</infon><infon key="type">ref</infon><infon key="volume">127</infon><infon key="section_type">REF</infon><infon key="lpage">7</infon><offset>42280</offset><text>Selective malabsorption of vitamin B12: report of a case with metabolic studies</text></passage><passage><infon key="name_3">surname:Tomihara-Newberger;given-names:C</infon><infon key="name_2">surname:Haub;given-names:O</infon><infon key="name_1">surname:Manning;given-names:S</infon><infon key="name_0">surname:Kalantry;given-names:S</infon><infon key="fpage">412</infon><infon key="issue">4</infon><infon key="pub-id_pmid">11279523</infon><infon key="year">2001</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="section_type">REF</infon><infon key="lpage">6</infon><infon key="name_5">surname:Fangman;given-names:J</infon><infon key="name_4">surname:Lee;given-names:HG</infon><offset>42360</offset><text>The amnionless gene, essential for mouse gastrulation, encodes a visceral-endoderm-specific protein with an extracellular cysteine-rich domain</text><annotation id="14629"><infon key="identifier">81693</infon><infon key="type">Gene</infon><location offset="42364" length="10" /><text>amnionless</text></annotation></passage><passage><infon key="name_3">surname:Schlaefer;given-names:K</infon><infon key="name_2">surname:Wiesel;given-names:A</infon><infon key="name_1">surname:Stolz;given-names:G</infon><infon key="name_0">surname:Queisser-Luft;given-names:A</infon><infon key="fpage">163</infon><infon key="issue">3</infon><infon key="pub-id_pmid">12197558</infon><infon key="year">2002</infon><infon key="source">Arch Gynecol Obstet</infon><infon key="type">ref</infon><infon key="volume">266</infon><infon key="section_type">REF</infon><infon key="lpage">7</infon><infon key="name_4">surname:Spranger;given-names:J</infon><offset>42503</offset><text>Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998)</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>42644</offset><text>Bor MV, Cetin M, Aytac S, Altay C, Ueland PM, Nexo E. Long term biweekly 1 mg oral vitamin B12 ensures normal hematological parameters, but does not correct all other markers of vitamin B12 deficiency. A study in patients with inherited vitamin B12 deficiency. Volume 93. Haematologica. Italy; 2008. pp. 1755-8.</text></passage><passage><infon key="volume">91</infon><infon key="name_1">surname:Nexo;given-names:E</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Hvas;given-names:AM</infon><infon key="fpage">1506</infon><infon key="issue">11</infon><infon key="pub-id_pmid">17043022</infon><infon key="year">2006</infon><infon key="source">Haematologica</infon><infon key="type">ref</infon><infon key="lpage">12</infon><offset>42960</offset><text>Diagnosis and treatment of vitamin B12 deficiency. An update</text></passage><relation id="R1"><infon key="score">0.9737</infon><infon key="role1">Chemical|MESH:D014805</infon><infon key="role2">Disease|MESH:D011507</infon><infon key="type">Negative_Correlation</infon></relation><relation id="R2"><infon key="score">0.9985</infon><infon key="role1">Chemical|MESH:D014805</infon><infon key="role2">Disease|MESH:C538556</infon><infon key="type">Negative_Correlation</infon></relation></document>
</collection>